Section 9

EurekaMag PDF full texts Chapter 8,176


Tirosh, O.; Katzhendler, Y.; Barenholz, Y.; Ginsburg, I.; Kohen, R. 1996: Antioxidant properties of amidothionophosphates: Novel antioxidant molecules. Free Radical Biology and Medicine 20(3): 421-432
Yoshikawa, T.; Minamiyama, Y.; Naito, Y.; Kondo, M. 1994: Antioxidant properties of bromocriptine, a dopamine agonist. Journal of Neurochemistry 62(3): 1034-1038
Duan, S.; Weng, X.C.; Dong, X.W.; Liu, Y.P.; Li, H.P.; Jin, J.R. 1998: Antioxidant properties of butylated hydroxytoluene refluxed in ferric chloride solution. Food Chemistry 61(1-2): 101-105
Roedig Penman, A.; Gordon, M.H. 1997: Antioxidant properties of catechins and green tea extracts in model food emulsions. Journal of Agricultural and Food Chemistry 45(11): 4267-4270
Rajakumar, D.V.; Rao, M.N. 1994: Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Molecular and cellular biochemistry 140(1): 73-79
Ko, F.N.; Liao, C.H.; Kuo, Y.H.; Lin, Y.L. 1995: Antioxidant properties of demethyldiisoeugenol. Biochimica Et Biophysica Acta 1258(2): 145-152
Kauder, W.F.; Watts, J.A. 1996: Antioxidant properties of dihydropyridines in isolated rat hearts. Biochemical Pharmacology 51(6): 811-819
Teselkin, I.O.; Zhambalova, B.A.; Babenkova, I.V.; Tiukavkina, N.A. 1996: Antioxidant properties of dihydroquercetin. Biofizika 41(3): 620-624
Xie, B.; Shi, H.; Chen, Q.; Ho, C.T. 1993: Antioxidant properties of fractions and polyphenol constituents from green, oolong and black teas. Proceedings of the National Science Council Republic of China. Part B Life Sciences 17(2): 77-84
Cohn, L.A.; Kinnula, V.L.; Adler, K.B. 1994: Antioxidant properties of guinea pig tracheal epithelial cells in vitro. American Journal of Physiology 266(4 Pt 1): L397-L404
Cotelle, N.; Bernier, J.L.; Catteau, J.P.; Pommery, J.; Wallet, J.C.; Gaydou, E.M. 1996: Antioxidant properties of hydroxy-flavones. Free Radical Biology and Medicine 20(1): 35-43
Vergely, C.; Walker, M.K.; Zeller, M.; Rademakers, J.R.; Maupoil, V.; Schiavi, P.; Guez, D.; Rochette, L. 1998: Antioxidant properties of indapamide, 5-OH indapamide and hydrochlorothiazide evaluated by oxygen-radical absorbing capacity and electron paramagnetic resonance. Molecular and Cellular Biochemistry 178(1-2): 151-155
Shimoni, E.; Armon, R.; Neeman, I. 1998: Antioxidant properties of lipid fractions from Deinococcus radiophilus strain UWO1055. Journal of Applied Microbiology 84(3): 461-465
Roedig Penman, A.; Gordon, M.H. 1998: Antioxidant properties of myricetin and quercetin in oil and emulsions. Journal Of The American Oil Chemists' Society. 75(2): 169-180,.
Tanaka, M.; Yoshida, T.; Okamoto, K.; Hirai, S. 1998: Antioxidant properties of nicergoline; inhibition of brain auto-oxidation and superoxide production of neutrophils in rats. Neuroscience Letters 248(1): 68-72
Suzuki, Y.J.; Tsuchiya, M.; Safadi, A.; Kagan, V.E.; Packer, L. 1992: Antioxidant properties of nitecapone (OR-462). Free Radical Biology and Medicine 13(5): 517-525
Grenier, J.L.; Cotelle, N.; Cotelle, P.; Catteau, J.P. 1996: Antioxidant properties of nitrocaffeic acids. Bioorganic and Medicinal Chemistry Letters 6(4): 431-434
Lapenna, D.; de Gioia, S.; Ciofani, G.; Festi, D.; Cuccurullo, F. 1996: Antioxidant properties of omeprazole. Febs Letters 382(1-2): 189-192
Quinn, L.A.; Tang, H.H. 1996: Antioxidant properties of phenolic compounds in Macadamia nuts. Journal of the American Oil Chemists' Society 73(11): 1585-1588
Mooradian, A.D. 1993: Antioxidant properties of steroids. Journal of Steroid Biochemistry and Molecular Biology 45(6): 509-511
Vani, T.; Rajani, M.; Sarkar, S.; Shishoo, C.J. 1997: Antioxidant properties of the ayurvedic formulation Triphala and its constituents. International Journal of Pharmacognosy 35(5): 313-317
Pecci, L.; Montefoschi, G.; Antonucci, A.; Cavallini, D. 1995: Antioxidant properties of the decarboxylated dimer of aminoethylcysteine ketimine. Physiological Chemistry and Physics and Medical Nmr 27(3): 223-229
Ahotupa, M.; Mäntylä, E.; Kangas, L. 1997: Antioxidant properties of the triphenylethylene antiestrogen drug toremifene. Naunyn-Schmiedeberg's Archives of Pharmacology 356(3): 297-302
Lapenna, D.; de Gioia, S.; Ciofani, G.; Bruno, C.; Porreca, E.; Pierdomenico, S.D.; Cuccurullo, F. 1998: Antioxidant properties of ticlopidine on human low density lipoprotein oxidation. Febs Letters 436(3): 357-360
Boney, S.C.; Hernandez, T.M.; Mattia, C. 1994: Antioxidant properties of two ayurvedic herbal preparations. Biochemical Archives 10(1): 25-31
Gutteridge, J.M.; Quinlan, G.J. 1992: Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: The important primary role for iron-binding and iron-oxidising proteins. Biochimica et Biophysica Acta 1159(3): 248-254
Shwaery, G.T.; Vita, J.A.; Keaney, J.F. 1998: Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol. Atherosclerosis 138(2): 255-262
Lilley, E.; Gibson, A. 1996: Antioxidant protection of NO-induced relaxations of the mouse anococcygeus against inhibition by superoxide anions, hydroquinone and carboxy-PTIO. British Journal of Pharmacology 119(2): 432-438
Santiago, L.A.; Osato, J.A.; Ogawa, N.; Mori, A. 1993: Antioxidant protection of bio-normalizer in cerebral ischaemia-reperfusion injury in the gerbil. Neuroreport 4(8): 1031-1034
Gould, T.J.; Chadman, K.; Bickford, P.C. 1998: Antioxidant protection of cerebellar beta-adrenergic receptor function in aged F344 rats. Neuroscience Letters 250(3): 165-168
Gabrielska, J.; Sarapuk, J.; Przestalski, S. 1995: Antioxidant protection of egg lecithin liposomes during sonication. Zeitschrift für Naturforschung. C Journal of Biosciences 50(7-8): 561-564
Pieper, G.M.; Dondlinger, L.A. 1998: Antioxidant pyrrolidine dithiocarbamate prevents defective bradykinin-stimulated calcium accumulation and nitric oxide activity following exposure of endothelial cells to elevated glucose concentration. Diabetologia 41(7): 806-812
Tesoriere, L.; D'Arpa, D.; Re, R.; Livrea, M.A. 1997: Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration. Archives of Biochemistry and Biophysics 343(1): 13-18
Liebler, D.C.; McClure, T.D. 1996: Antioxidant reactions of beta-carotene: identification of carotenoid-radical adducts. Chemical Research in Toxicology 9(1): 8-11
Bisby, R.H.; Parker, A.W. 1998: Antioxidant reactions of dihydrolipoic acid and lipoamide with triplet duroquinone. Biochemical and Biophysical Research Communications 244(1): 263-267
Ham, A.J.; Liebler, D.C. 1997: Antioxidant reactions of vitamin E in the perfused rat liver: product distribution and effect of dietary vitamin E supplementation. Archives of Biochemistry and Biophysics 339(1): 157-164
Abdelaal, A.N.; Khalil, S.A. 1996: Antioxidant red cell protective enzymes in lymphoma patients. Journal of the Medical Research Institute 17(1): 13-21
Roy, S.; Sen, C.K.; Kobuchi, H.; Packer, L. 1998: Antioxidant regulation of phorbol ester-induced adhesion of human Jurkat T-cells to endothelial cells. Free Radical Biology and Medicine 25(2): 229-241
Gossett, D.R.; Millhollon, E.P.; Lucas, M.C.an 1994: Antioxidant response to NaCl stress in salt-tolerant and salt-sensitive cultivars of cotton. Crop Science 34(3): 706-714
Dansa-Petretski, M.; Ribeiro, J.M.; Atella, G.C.; Masuda, H.; Oliveira, P.L. 1995: Antioxidant role of Rhodnius prolixus heme-binding protein. Protection against heme-induced lipid peroxidation. Journal of Biological Chemistry 270(18): 10893-10896
Kobayashi, M.; Kakizono, T.; Nishio, N.; Nagai, S.; Kurimura, Y.; Tsuji, Y. 1997: Antioxidant role of astaxanthin in the green alga Haematococcus pluvialis. Applied Microbiology and Biotechnology 48(3): 351-356
Schroeder, W.A.; Johnson, E.A. 1993: Antioxidant role of carotenoids in Phaffia rhodozyma. Journal of General Microbiology 139(5): 907-912
Abuja, P.M.; Liebmann, P.; Hayn, M.; Schauenstein, K.; Esterbauer, H. 1997: Antioxidant role of melatonin in lipid peroxidation of human LDL. Febs Letters 413(2): 289-293
Marzatico, F.; Gaetani, P.; Tartara, F.; Bertorelli, L.; Feletti, F.; Adinolfi, D.; Tancioni, F.; Rodriguez y Baena, R. 1998: Antioxidant status and alpha1-antiproteinase activity in subarachnoid hemorrhage patients. Life Sciences 63(10): 821-826
Viguie, C.A.; Frei, B.; Shigenaga, M.K.; Ames, B.N.; Packer, L.; Brooks, G.A. 1993: Antioxidant status and indexes of oxidative stress during consecutive days of exercise. Journal of Applied Physiology 75(2): 566-572
Gauchez, A.S.; Riondel, J.; Jacrot, M.; Calop, J.; Favier, A. 1995: Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors. Biological Trace Element Research 47(1-3): 103-109
Young, I.S.; Trouton, T.G.; Torney, J.J.; McMaster, D.; Callender, M.E.; Trimble, E.R. 1994: Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radical Biology and Medicine 16(3): 393-397
Inal, M.; Kanbak, G. 1997: Antioxidant status and lipid peroxidation in red blood cells of p-aminophenol-treated rats. Medical Science Research 25(5): 323-325
Yannuzzi, L.A.; Sorenson, J.A.; Sobel, R.S.; Daly, J.R.; Derosa, J.T.; Seddon, J.M.; Gragoudas, E.S.; Puliafito, C.A.; Gelles, E. 1993: Antioxidant status and neovascular age-related macular degeneration. Archives of Ophthalmology 111(1): 104-109
Seven, A.; Seymen, O.; Hatemi, S.; Hatemi, H.; Yiğit, G.; Candan, G. 1996: Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation. Clinica Chimica Acta; International Journal of Clinical Chemistry 256(1): 65-74
Sierra, C.; Vilaseca, M.A.; Moyano, D.; Brandi, N.; Campistol, J.; Lambruschini, N.; Cambra, F.J.; Deulofeu, R.; Mira, A. 1998: Antioxidant status in hyperphenylalaninemia. Clinica Chimica Acta; International Journal of Clinical Chemistry 276(1): 1-9
Koenig, J.S.; Fischer, M.; Bulant, E.; Tiran, B.; Elmadfa, I.; Druml, W. 1997: Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wiener Klinische Wochenschrift 109(1): 13-19
Maxwell, S.R.; Thomason, H.; Sandler, D.; Leguen, C.; Baxter, M.A.; Thorpe, G.H.; Jones, A.F.; Barnett, A.H. 1997: Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 27(6): 484-490
Picardo, M.; Passi, S.; Morrone, A.; Grandinetti, M.; Di Carlo, A.; Ippolito, F. 1994: Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Research 7(2): 110-115
Di Simplicio, P.; Rossi, R.; Falcinelli, S.; Ceserani, R.; Formento, M.L. 1997: Antioxidant status in various tissues of the mouse after fasting and swimming stress. European Journal of Applied Physiology and Occupational Physiology 76(4): 302-307
Godin, D.V.; Cheng, K.M.; Garnett, M.E.; Nichols, C.R. 1994: Antioxidant status of Japanese quail: comparison of atherosclerosis-susceptible and -resistant strains. Canadian Journal of Cardiology 10(2): 221-228
Bopanna, K.N.; Balaraman, R.; Nadig, R.S. 1998: Antioxidant status of S-allyl cysteine sulphoxide on monosodium glutamate potentiated atherogenesis. Indian Journal of Pharmacology 30(2): 73-81
Bonnefont-Rousselot, D.; Jaudon, M.C.; Issad, B.; Cacoub, P.; Congy, F.; Jardel, C.; Delattre, J.; Jacobs, C. 1997: Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 12(7): 1399-1405
Skrzydlewska, E.; Farbiszewski, R. 1997: Antioxidant status of liver, erythrocytes, and blood serum of rats in acute methanol intoxication. Alcohol 14(5): 431-437
Garg, M.C.; Ojha, S.; Bansal, D.D. 1996: Antioxidant status of streptozotocin diabetic rats. Indian Journal of Experimental Biology 34(3): 264-266
Sathiyaraj, D.; Muthu, R.; Mohamed, A.J.mal 1997: Antioxidant status, proinflammatory cytokines, and acute-phase protein response in smokers after myocardial infarction. Journal of Clinical Biochemistry and Nutrition 22(2): 131-137
Duthie, S.J.; Ma, A.; Ross, M.A.; Collins, A.R. 1996: Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Research 56(6): 1291-1295
van Jaarsveld, H.; Kuyl, J.M.; Alberts, D.W.; Wiid, M.N. 1994: Antioxidant supplementation partially protects against myocardial mitochondrial ischemia/reperfusion injury, but ascorbate in the perfusate prevented the beneficial effect. Research Communications in Molecular Pathology and Pharmacology 85(1): 33-44
Baker, H.; Deangelis, B.; Frank, O.; Khalil, M.; Hutner, S.H.; Baker, E.R. 1996: Antioxidant survey to assess antagonism to redox stress using a prokaryotic and an eukaryotic system. Experientia 52(6): 597-599
Bruun-Jensen, L.; Skovgaard, I.M.; Skibsted, L.H.; Bertelsen, G. 1994: Antioxidant synergism between tocopherols and ascorbyl palmitate in cooked, minced turkey. Zeitschrift für Lebensmittel-Untersuchung und -Forschung 199(3): 210-213
Weng, X.C.; Gordon, M.H. 1993: Antioxidant synergy between phosphatidylethanolamine and alpha-tocopherylquinone. Food Chemistry 48(2): 165-168
Pokshubina, E.V.; Etkina, E.I.; Davletov, E.G.; Nagaeva, G.M.; Biktasheva, A.R. 1997: Antioxidant system and endocrine functions in children of oil industry center. Meditsina Truda i Promyshlennaya Ekologiya 1997(8): 8-11
Sgherri, C.-Luisa-Maria; Loggini, B.; Bochicchio, A.; Navari-Izzo, F. 1994: Antioxidant system in Boea hygroscopica: Changes in response to desiccation and rehydration. Phytochemistry 37(2): 377-381
Sitarska, E.; Kleczkowski, M.; Klucinski, W.; Ladysz, R.; Gorecka, R.; Dziekan, P. 1997: Antioxidant system in horses and attempts for its modulation. Medycyna Weterynaryjna 53(10): 585-588
Bauché, F.; Fouchard, M.H.; Jégou, B. 1994: Antioxidant system in rat testicular cells. Febs Letters 349(3): 392-396
González, M.E.; Francis, L.; Castellano, O. 1998: Antioxidant systemic effect of short-term Cerebrolysin administration. Journal of Neural Transmission. Supplementum 53: 333-341
Willmore, W.G.; Storey, K.B. 1997: Antioxidant systems and anoxia tolerance in a freshwater turtle Trachemys scripta elegans. Molecular and Cellular Biochemistry 170(1-2): 177-185
Kurata, M.; Suzuki, M.; Agar, N.S. 1993: Antioxidant systems and erythrocyte life-span in mammals. Comparative Biochemistry and Physiology. B Comparative Biochemistry 106(3): 477-487
Lebedeva, E.A. 1996: Antioxidant systems of blood plasma in the pathogenesis of diabetic microangiopathies. Problemy Endokrinologii 42(5): 10-12
Alio, J.L.; Ayala, M.J.; Mulet, M.E.; Artola, A.; Ruiz, J.M.; Bellot, J. 1995: Antioxidant therapy in the treatment of experimental acute corneal inflammation. Ophthalmic Research 27(3): 136-143
Inan, C.; Kilinç, K.; Kotiloğlu, E.; Akman, H.O.; Kiliç, I.; Michl, J. 1998: Antioxidant therapy of cobalt and vitamin E in hemosiderosis. Journal of Laboratory and Clinical Medicine 132(2): 157-165
Burnusus, Z.I. 1992: Antioxidant therapy of pulmonary tuberculosis in chronic alcoholics. Problemy Tuberkuleza 1992(5-6): 28-30
Denis, M. 1995: Antioxidant therapy partially blocks immune-induced lung fibrosis. Inflammation 19(2): 207-219
Cerwenka, H.; Bacher, H.; Werkgartner, G.; El-Shabrawi, A.; Quehenberger, F.; Hauser, H.; Mischinger, H.J. 1998: Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepato-Gastroenterology 45(21): 777-782
Nikolaev, M.P.; Logunov, A.I.; Tsyrul'nikova, L.G.; Dzhalilov, D.S. 1994: Antioxidant treatment of acute maxillary sinusitides: Clinical and biochemical rationale. Vestnik Otorinolaringologii 1994(1): 22-26
Hammes, H.P.; Bartmann, A.; Engel, L.; Wülfroth, P. 1997: Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40(6): 629-634
Rotrosen, J.; Adler, L.; Lohr, J.; Edson, R.; Lavori, P. 1996: Antioxidant treatment of tardive dyskinesia. Prostaglandins Leukotrienes and Essential Fatty Acids 55(1-2): 77-81
Nakao, N.; Grasbon-Frodl, E.M.; Widner, H.; Brundin, P. 1996: Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 73(1): 185-200
Sack, C.A.; Socci, D.J.; Crandall, B.M.; Arendash, G.W. 1996: Antioxidant treatment with phenyl-alpha-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neuroscience Letters 205(3): 181-184
Fomenko, L.A.; Bezlepkina, T.A.; Anoshkin, A.N.; Gaziev, A.I. 1997: Antioxidant vitamin diet decreases the rate of chromosomal damage and genic mutation in irradiated mice. Izvestiya Akademii Nauk Seriya Biologicheskaya (Moscow) 1997(4): 419-424
Knekt, P.; Reunanen, A.; Järvinen, R.; Seppänen, R.; Heliövaara, M.; Aromaa, A. 1994: Antioxidant vitamin intake and coronary mortality in a longitudinal population study. American Journal of Epidemiology 139(12): 1180-1189
Hennekens, C.H.; Gaziano, J.M.; Manson, J.E.; Buring, J.E. 1995: Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: the need for randomized trials. American Journal of Clinical Nutrition 62(6 Suppl): 1377s-1380s
Fuentes, A.M.; Amábile-Cuevas, C.F. 1998: Antioxidant vitamins C and e affect the superoxide-mediated induction of the soxRS regulon of Escherichia coli. Microbiology 144: 1731-1736
Hennekens, C.H. 1994: Antioxidant vitamins and cancer. American Journal of Medicine 97(3a): 2s-4s; Discussion 22s-28s
Gaziano, J.M. 1994: Antioxidant vitamins and coronary artery disease risk. American Journal of Medicine 97(3a): 18s-21s; Discussion 22s-28s
Ravaglia, G.; Maioli, P. Forti F.; De Ronchi, D.; Boschi, F.; Scali, R.C.; Cavazzani, M.; Bovina, C.; Bugiardini, R. 1998: Antioxidant vitamins and dementia. Archives of Gerontology and Geriatrics 1998(Suppl 6): 431-434
Ronucci, Luca; Di Donato, Paola; Carati, Livio; Ferrari, Alberto; Perini, Mario; Bertoni, Giorgio; Bedogni, Giuliano; Paris, Bruno; Svanoni, Fausto 1993: Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Diseases of the Colon and Rectum 36(3): 227-234
Inoue, M.; Suzuki, R.; Koide, T.; Sakaguchi, N.; Ogihara, Y.; Yabu, Y. 1994: Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochemical and Biophysical Research Communications 204(2): 898-904
Fukuda, M.; Ikegami, H.; Kawaguchi, Y.; Sano, T.; Ogihara, T. 1995: Antioxidant, probucol, can inhibit the generation of hydrogen peroxide in islet cells induced by macrophages and prevent islet cell destruction in NOD mice. Biochemical and Biophysical Research Communications 209(3): 953-958
Rösl, F.; Das, B.C.; Lengert, M.; Geletneky, K.; zur Hausen, H. 1997: Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. Journal of Virology 71(1): 362-370
English, N.T.; Rankin, L.C. 1997: Antioxidant-mediated attenuation of the induction of cytochrome P450BM-3(CYP102) by ibuprofen in Bacillus megaterium ATCC 14581. Biochemical Pharmacology 54(4): 443-450
Gwinner, W.; Deters-Evers, U.; Brandes, R.P.; Kubat, B.; Koch, K.M.; Pape, M.; Olbricht, C.J. 1998: Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney. Journal of Physiology 509: 599-606
Ramos, V.; Valenzuela, A.; Villanueva, E.; Miranda, M.T. 1997: Antioxidant-related enzymes in myocardial zones and human pericardial fluid in relation to the cause of death. International Journal of Legal Medicine 110(1): 1-4
Bongers, V.; de Jong, J.; Steen, I.; de Vries, N.; Bast, A.; Snow, G.B.; Braakhuis, B.J. 1995: Antioxidant-related parameters in patients treated for cancer chemoprevention with N-acetylcysteine. European Journal of Cancer 31a(6): 921-923
Offermann, M.K.; Lin, J.C.; Mar, E.C.; Shaw, R.; Yang, J.; Medford, R.M. 1996: Antioxidant-sensitive regulation of inflammatory-response genes in Kaposi's sarcoma cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 13(1): 1-11
Venditti, P.; De Leo, T.; Di Meo, S. 1998: Antioxidant-sensitive shortening of ventricular action potential in hyperthyroid rats is independent of lipid peroxidation. Molecular and Cellular Endocrinology 142(1-2): 15-23
Walther, F.J.; David-Cu, R.; Lopez, S.L. 1995: Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. American Journal of Physiology 269(5 Pt 1): L613-L617
Parthasarathy, S.; Morales, A.J.; Murphy, A.A. 1994: Antioxidant: a new role for RU-486 and related compounds. Journal of Clinical Investigation 94(5): 1990-1995
Gomez del Arco, P.; Martínez-Martínez, S.; Calvo, V.; Armesilla, A.L.; Redondo, J.M. 1997: Antioxidants and AP-1 activation: a brief overview. Immunobiology 198(1-3): 273-278
Christen, W.G.; Glynn, R.J.; Hennekens, C.H. 1996: Antioxidants and age-related eye disease. Current and future perspectives. Annals of Epidemiology 6(1): 60-66
Ishihara, N.; Yuzawa, M.; Tamakoshi, A. 1997: Antioxidants and angiogenetic factor associated with age-related macular degeneration (exudative type). Nippon Ganka Gakkai Zasshi 101(3): 248-251
Rautalahti, M.; Huttunen, J. 1994: Antioxidants and carcinogenesis. Annals of Medicine 26(6): 435-441
Christen, W.G. 1994: Antioxidants and eye disease. American Journal of Medicine 97(3a): 14s-17s; Discussion 22s-28s
Meydani, S.N.; Wu, D.; Santos, M.S.; Hayek, M.G. 1995: Antioxidants and immune response in aged persons: overview of present evidence. American Journal of Clinical Nutrition 62(6 Suppl): 1462s-1476s
Kruidenier, L.; Verspaget, H.W. 1998: Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?. Mediators of Inflammation 7(3): 157-162
Hoffman, R.M.; Garewal, H.S. 1995: Antioxidants and the prevention of coronary heart disease. Archives of Internal Medicine 155(3): 241-246
Müller, J.M.; Cahill, M.A.; Rupec, R.A.; Baeuerle, P.A.; Nordheim, A. 1997: Antioxidants as well as oxidants activate c-fos via Ras-dependent activation of extracellular-signal-regulated kinase 2 and Elk-1. European Journal of Biochemistry 244(1): 45-52
Zurovsky, Y.; Haber, C. 1995: Antioxidants attenuate endotoxin-gentamicin induced acute renal failure in rats. Scandinavian Journal of Urology and Nephrology 29(2): 147-154
Mendez, C.; Garcia, I.; Maier, R.V. 1995: Antioxidants attenuate endotoxin-induced activation of alveolar macrophages. Surgery 118(2): 412-420
Pfister, H.W.; Koedel, U.; Lorenzl, S.; Tomasz, A. 1992: Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke 23(12): 1798-1804
Wentzel, P.; Eriksson, U.J. 1998: Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes 47(4): 677-684
Chinery, R.; Brockman, J.A.; Peeler, M.O.; Shyr, Y.; Beauchamp, R.D.; Coffey, R.J. 1997: Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta. Nature Medicine 3(11): 1233-1241
Lam, X.M.; Yang, J.Y.; Cleland, J.L. 1997: Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. Journal of Pharmaceutical Sciences 86(11): 1250-1255
Studt, P.; Becker, R.; Knorr, A.; Hoffmann, W. 1993: Antioxidants for rapeseed oil. Fett Wissenschaft Technologie 95(3): 118-120
Bersuder, P.; Hole, M.; Smith, G. 1998: Antioxidants from a heated histidine-glucose model system. I. Investigation of the antioxidant role of histidine and isolation of antioxidants by high-performance liquid chromatography. Journal of the American Oil Chemists' Society 75(2): 181-187
Khan, M.A.; Jeremy, J.Y.; Hallinan, T.; Tateson, J.E.; Hoffbrand, A.V.; Wickremasinghe, R.G. 1993: Antioxidants impair the coupling of cell-surface ligand receptors to the inositol lipid signalling pathway in human T lymphocytes but not in Jurkat T lymphoblastic leukemia cells. Evidence that leukotrienes are not involved in the coupling mechanism. Biochimica et Biophysica Acta 1178(2): 215-220
Kardinaal, A.F.; Kok, F.J.; Ringstad, J.; Gomez-Aracena, J.; Mazaev, V.P.; Kohlmeier, L.; Martin, B.C.; Aro, A.; Kark, J.D.; Delgado-Rodriguez, M. 1993: Antioxidants in adipose tissue and risk of myocardial infarction: The EURAMIC study. Lancet 342(8884): 1379-1384
Kodavanti, U.P.; Costa, D.L.; Richards, J.; Crissman, K.M.; Slade, R.; Hatch, G.E. 1996: Antioxidants in bronchoalveolar lavage fluid cells isolated from ozone--exposed normal and ascorbate-deficient guinea pigs. Experimental Lung Research 22(4): 435-448
Biesalski, H.K.; Frank, J. 1995: Antioxidants in nutrition and their importance for the anti-/prooxidative balance in the immune system. Immunitaet und Infektion 23(5): 166-173
Romero, F.J. 1996: Antioxidants in peripheral nerve. Free Radical Biology and Medicine 20(7): 925-932
Asayama, K.; Uchida, N.; Nakane, T.; Hayashibe, H.; Dobashi, K.; Amemiya, S.; Kato, K.; Nakazawa, S. 1993: Antioxidants in the serum of children with insulin-dependent diabetes mellitus. Free Radical Biology and Medicine 15(6): 597-602
Gülmezoğlu, A.M.; Hofmeyr, G.J.; Oosthuisen, M.M. 1997: Antioxidants in the treatment of severe pre-eclampsia: An explanatory randomised controlled trial. British Journal of Obstetrics and Gynaecology 104(6): 689-696
Serebryanyi, A.M.; Zoz, N.N. 1993: Antioxidants increase the adaptive response of seeds during radiation mutagenesis of wheat plants. Radiobiologiya 33(1): 81-87
Wei, E.P.; Kontos, H.A.; Beckman, J.S. 1998: Antioxidants inhibit ATP-sensitive potassium channels in cerebral arterioles. Stroke 29(4): 817
Tetsuka, T.; Baier, L.D.; Morrison, A.R. 1996: Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric-oxide synthase expression in rat mesangial cells. Evidence for post-transcriptional regulation. Journal of Biological Chemistry 271(20): 11689-11693
Staal, F.J.; Roederer, M.; Raju, P.A.; Anderson, M.T.; Ela, S.W.; Herzenberg, L.A.; Herzenberg, L.A. 1993: Antioxidants inhibit stimulation of HIV transcription. Aids Research and Human Retroviruses 9(4): 299-306
Wölfle, D.; Marquardt, H. 1996: Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 17(6): 1273-1278
Cominacini, L.; Garbin, U.; Pasini, A.F.; Davoli, A.; Campagnola, M.; Contessi, G.B.; Pastorino, A.M.; Lo Cascio, V. 1997: Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells. Free Radical Biology and Medicine 22(1-2): 117-127
Reimund, J.M.; Allison, A.C.; Muller, C.D.; Dumont, S.; Kenney, J.S.; Baumann, R.; Duclos, B.; Poindron, P. 1998: Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis. European Journal of Clinical Investigation 28(2): 145-150
Sato, M.; Miyazaki, T.; Nagaya, T.; Murata, Y.; Ida, N.; Maeda, K.; Seo, H. 1996: Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1, and collagenase expression in cultured human synovial cells. Journal of Rheumatology 23(3): 432-438
Boo, Y.C.; Jeon, C.O. 1993: Antioxidants of Theae Folium and Moutan Cortex. Journal of the Korean Agricultural Chemical Society 36(5): 326-331
Graier, W.F.; Simecek, S.; Hoebel, B.G.; Wascher, T.C.; Dittrich, P.; Kostner, G.M. 1997: Antioxidants prevent high-D-glucose-enhanced endothelial Ca2+/cGMP response by scavenging superoxide anions. European Journal of Pharmacology 322(1): 113-122
LaLonde, C.; Nayak, U.; Hennigan, J.; Demling, R. 1996: Antioxidants prevent the cellular deficit produced in response to burn injury. Journal of Burn Care and Rehabilitation 17(5): 379-383
Ricardo, S.D.; Bertram, J.F.; Ryan, G.B. 1994: Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. Journal of the American Society of Nephrology: Jasn 4(12): 1974-1986
Mohanraj, P.; Merola, A.J.; Wright, V.P.; Clanton, T.L. 1998: Antioxidants protect rat diaphragmatic muscle function under hypoxic conditions. Journal of Applied Physiology 84(6): 1960-1966
Chinery, R.; Beauchamp, R.D.; Shyr, Y.; Kirkland, S.C.; Coffey, R.J.; Morrow, J.D. 1998: Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Cancer Research 58(11): 2323-2327
Kristal, B.S.; Park, B.J.; Yu, B.P. 1994: Antioxidants reduce peroxyl-mediated inhibition of mitochondrial transcription. Free Radical Biology and Medicine 16(5): 653-660
Trachtman, H.; Futterweit, S.; Prenner, J.; Hanon, S. 1994: Antioxidants reverse the antiproliferative effect of high glucose and advanced glycosylation end products in cultured rat mesangial cells. Biochemical and Biophysical Research Communications 199(1): 346-352
Keogh, B.; Allen, R.G.; Tresini, M.; Furth, J.J.; Cristofalo, V.J. 1998: Antioxidants stimulate transcriptional activation of the c-fos gene by multiple pathways in human fetal lung fibroblasts (WI-38). Journal of Cellular Physiology 176(3): 624-633
Eun, J.B.; Hearnsberger, J.O.; Kim, J.M. 1993: Antioxidants, activators, and inhibitors affect the enzymic lipid peroxidation system of catfish muscle microsomes. Journal of Food Science 58(1): 71-74
Foga, I.O.; Nath, A.; Hasinoff, B.B.; Geiger, J.D. 1997: Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 16(4): 223-229
Katsuki, H.; Akino, N.; Okuda, S.; Saito, H. 1995: Antioxidants, but not cAMP or high K+, prevent arachidonic acid toxicity on neuronal cultures. Neuroreport 6(8): 1101-1104
Winder, A.F. 1997: Antioxidants, cholesterol, and ischaemic heart disease: CHAOS or confusion?. Journal of Clinical Pathology 50(4): 269-270
Pérez-Pinzón, M.A.; Mumford, P.L.; Rosenthal, M.; Sick, T.J. 1997: Antioxidants, mitochondrial hyperoxidation and electrical recovery after anoxia in hippocampal slices. Brain Research 754(1-2): 163-170
Gutteridge, J.M. 1994: Antioxidants, nutritional supplements and life-threatening diseases. British Journal of Biomedical Science 51(3): 288-295
Venditti, P.; Di Meo, S. 1996: Antioxidants, tissue damage, and endurance in trained and untrained young male rats. Archives of Biochemistry and Biophysics 331(1): 63-68
Kapich, A.N. 1995: Antioxidation activity of mycelium extracts of xylotrophic basidiomycetes. Mikologiya i Fitopatologiya 29(5-6): 35-40
Shen Fanglan, Zhang Xiuzhen; Li Juesheng; Zhang Zaixiang; Duan Jianhua; Wang Jianhua 1996: Antioxidation and DNA repair ability of taurine in mice. Acta Nutrimenta Sinica 18(3): 258-262
Wu, T.W.; Fung, K.P.; Yang, C.C.; Weisel, R.D. 1995: Antioxidation of human low density lipoprotein by morin hydrate. Life Sciences 57(3): Pl51-Pl56
Wu, T.W.; Fung, K.P.; Wu, J.; Yang, C.C.; Weisel, R.D. 1996: Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochemical Pharmacology 51(6): 859-862
Bobkova, L.S.; Sharykina, N.I.; Kudryavtseva, I.H.; Ovruts'kyi, V.M.; Shchumeiko, V.M.; Kolyadych, O.P.; Ovruts'kyi, O.V. 1997: Antioxidation properties of the anticancer substances: Natulan and 3(2',3',4'-oxy- and 4'-methoxyphenyliminomethyl)pyridines. Farmatsevtychnyi Zhurnal (Kiev) 1997(2): 79-82
Aniya, Y.; Fong, K.F.; Naito, A.; Sakanashi, M. 1995: Antioxidative action of the beta-adrenoceptor antagonist bopindolol and its metabolite 18-502. Japanese Journal of Pharmacology 68(3): 323-329
Kojima, S.; Iizuka, H.; Yamaguchi, H.; Tanuma, S.; Kochi, M.; Ueno, Y. 1994: Antioxidative activity of benzylideneascorbate and its effect on adriamycin-induced cardiotoxicity. Anticancer Research 14(5a): 1875-1880
Yamamoto, Y.kiko; Omori, Miki 1994: Antioxidative Activity of Egg Yolk Lipoproteins. Bioscience Biotechnology and Biochemistry 58(9): 1711-1713
Tagashira, M.; Watanabe, M.; Uemitsu, N. 1995: Antioxidative activity of hop bitter acids and their analogues. Bioscience Biotechnology and Biochemistry 59(4): 740-742
Tamura, H.; Yamagami, A. 1994: Antioxidative Activity of Monoacylated Anthocyanins Isolated from Muscat Bailey A Grape. Journal of Agricultural and Food Chemistry 42(8): 1612-1615
Minamiyama, Y.; Yoshikawa, T.; Tanigawa, T.; Takahashi, S.; Naito, Y.; Ichikawa, H.; Kondo, M. 1994: Antioxidative effects of a processed grain food. Journal of Nutritional Science and Vitaminology 40(5): 467-477
Bedinghaus, A.J.; Ockerman, H.W. 1995: Antioxidative Maillard reaction products from reducing sugars and free amino acids in cooked ground pork patties. Journal of Food Science 60(5): 992-995
Cai, Q.; Takemura, G.; Ashraf, M. 1995: Antioxidative properties of histidine and its effect on myocardial injury during ischemia/reperfusion in isolated rat heart. Journal of Cardiovascular Pharmacology 25(1): 147-155
Jiang, Y.; Zhong, G.G.; Qi, H.; Ma, X.Y. 1993: Antioxidative action of soyasaponin monomers I, A1, A2, and their inhibitory effects on action potential and beating of myocardiocytes in culture. Zhongguo Yao Li Xue Bao 14(3): 269-273
Marinova, E.M.; Yanishlieva, N.V.; Kostova, I.N. 1994: Antioxidative action of the ethanolic extract and some hydroxycoumarins of Fraxinus ornus bark. Food Chemistry 51(2): 125-132
Naito, A.; Aniya, Y.; Sakanashi, M. 1994: Antioxidative action of the nitrovasodilator nicorandil: inhibition of oxidative activation of liver microsomal glutathione S-transferase and lipid peroxidation. Japanese Journal of Pharmacology 65(3): 209-213
Eiserich, J.P.; Wong, J.W.; Shibamoto, T. 1995: Antioxidative activities of furan- and thiophenethiols measured in lipid peroxidation systems and by tyrosyl radical scavenging assay. Journal of Agricultural and Food Chemistry 43(3): 647-650
Xue, C.; Yu, G.; Hirata, T.; Terao, J.; Lin, H. 1998: Antioxidative activities of several marine polysaccharides evaluated in a phosphatidylcholine-liposomal suspension and organic solvents. Bioscience Biotechnology and Biochemistry 62(2): 206-209
Ji, C.I.; Kang, J.H.; Park, Y.B.; Lee, T.G.; Kim, S.B.; Park, Y.H. 1992: Antioxidative activities of spices extracts on peroxidation of refined sardine oil. Bulletin of the Korean Fisheries Society 25(5): 325-330
Ishii, G.; Mori, M.; Umemura, Y. 1996: Antioxidative activity and food chemical properties of anthocyanins from the colored tuber flesh of potatoes. Journal of Japanese Society of Food Science and Technology 43(8): 962-966
Yen, G.C.; Hsieh, P.P. 1995: Antioxidative activity and scavenging effects on active oxygen of xylose-lysine maillard reaction products. Journal of the Science of Food and Agriculture 67(3): 415-420
Chiou, Robin, Y.Y. 1992: Antioxidative activity in oils prepared from peanut kernels subjected to various treatments and roasting. Journal of Agricultural and Food Chemistry 40(10): -1962
Blekas, G.; Boskou, D. 1998: Antioxidative activity of 3,4-dihydroxyphenylacetic acid and alpha-tocopherol on the triglyceride matrix of olive oil. Effect of acidity. Grasas y Aceites 49(1): 34-37
Wu, Y.J.; Li, W.G.; Zhang, Z.M.; Tian, X. 1997: Antioxidative activity of 4-oxy- and 4-hydroxy-nitroxides in tissues and erythrocytes from rats. Zhongguo Yao Li Xue Bao 18(2): 150-154
Chiue, H.; Kusano, T.; Iwami, K. 1997: Antioxidative activity of barley hordein and its loss by deamidation. Journal of Nutritional Science and Vitaminology 43(1): 145-154
Kitta, K.; Hagiwara, Y.; Shibamoto, T. 1992: Antioxidative activity of an isoflavonoid, 2-O-glycosylisovitexin isolated from green barley leaves. Journal of Agricultural and Food Chemistry 40(10): 1843-1845
Watanabe, M.; Sato, A.; Osawa, R.; Terao, J. 1995: Antioxidative activity of buckwheat seed extracts and its rapid estimate for evaluation of breeding materials. Journal of Japanese Society of Food Science and Technology 42(9): 649-655
Takenaka, T.; Kuwabara, M.; Yatsunami, K. 1996: Antioxidative activity of caramel on linoleic acid (Glucose-Sodium Citrate System). Bulletin of the Faculty of Agriculture, Tamagawa University 36: 1-9
Xue, C.; Yu, G.; Hirata, T.; Sakaguchi, M.; Terao, J. 1998: Antioxidative activity of carp blood plasma on lipid peroxidation. Bioscience Biotechnology and Biochemistry 62(2): 201-205
Suzuki, N.; Hatate, H.; Kanamori, N.; Nomoto, T.; Namiki, M.; Yoda, B. 1995: Antioxidative activity of chlorophyll derivatives, oxygen stress relievers, to superoxide measured by using Cypridina luciferin analogues. Fisheries Science 61(1): 65-67
Ohta, T.; Yamasaki, S.; Egashira, Y.; Sanada, H. 1994: Antioxidative activity of corn bran hemicellulose fragments. Journal of Agricultural and Food Chemistry 42(3): 653-656
Yeum, D.M.; Lee, T.G.; Park, Y.H.; Kim, S.B. 1997: Antioxidative activity of enzymatic hydrolysates derived from anchovy muscle protein. Journal of the Korean Fisheries Society 30(5): 842-849
Chen, Z.Y.; Wang, L.Y.; Chan, P.T.; Zhang, Z.; Chung, H.Y.; Liang, C. 1998: Antioxidative activity of green tea catechin extract compared with that or rosemary extract. Journal of the American Oil Chemists' Society 75(9): 1141-1145
Chen, Z.Y.; Chan, P.T. 1996: Antioxidative activity of green tea catechins in canola oil. Chemistry and Physics of Lipids 82(2): 163-172
Smith, J.S.; Alfawaz, M. 1995: Antioxidative activity of maillard reaction products in cooked ground beef, sensory and TBA values. Journal of Food Science 60(2): 234-236, 240
Wong, R.G.; Yen, G.C. 1997: Antioxidative activity of mungbean sprouts, soybean sprouts and radish sprouts. Journal of the Chinese Agricultural Chemical Society 35(6): 661-670
Arendt, B.; Skibsted, L.H.; Andersen, H.J. 1997: Antioxidative activity of nitrite in metmyoglobin induced lipid peroxidation. Zeitschrift Fuer Lebensmittel-Untersuchung Und Forschung A. 204(1): 7-12
Hatate, H. 1996: Antioxidative activity of ovalbumin hydrolysates and their synergistic effects with alpha-tocopherol. Journal of Japanese Society of Food Science and Technology 43(6): 719-722
Chung, T.-Yung; Kim, M.-Ae; Jones, A.D.niel 1996: Antioxidative activity of phenolic acids isolated from Jindalrae flower (Rhododendron mucronulatum Turzaninow). Agricultural Chemistry and Biotechnology 39(6): 506-511
Marinov, E.M.; Yanishlieva, N.V. 1996: Antioxidative activity of phenolic acids on triacylglycerols and fatty acid methyl esters from olive oil. Food Chemistry 56(2): 139-145
Tamagawa, K.; IIzuka, S.; Fukushima, S.; Endo, Y.; Komiyama, Y. 1997: Antioxidative activity of polyphenol extracts from barley bran. Nippon Shokuhin Kagaku Kogaku Kaishi 44(7): 512-515
Alaiz, M.; Zamora, R.; Hidalgo, F.J. 1996: Antioxidative activity of pyrrole, imidazole, dihydropyridine, and pyridinium salt derivatives produced in oxidized lipid/amino acid browning reactions. Journal of Agricultural and Food Chemistry 44(3): 686-691
Ioku, K.; Tsushida, T.; Takei, Y.; Nakatani, N.; Terao, J. 1995: Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochimica Et Biophysica Acta 1234(1): 99-104
Tsuda, T.; Fujii, M.; Watanabe, M.; Nakakuki, H.; Ohshima, K.; Osawa, T.; Kawakishi, S. 1994: Antioxidative activity of red bean extract and its application to food. Journal of Japanese Society of Food Science and Technology 41(7): 475-480
Hattori, M.; Yamaji Tsukamoto, K.; Kumagai, H.; Feng, Y.; Takahashi, K. 1998: Antioxidative activity of soluble elastin peptides. Journal of Agricultural and Food Chemistry 46(6): 2167-2170
Ciurdaru, V.; Osianu, D.; Joldos, E.; Ciurdaru, G. 1992: Antioxidative activity of some vegetal materials. Revue Roumaine de Biochimie 29(2): 101-105
Ciurdaru, V.; Osianu, D.; Joldos, E.; Lujerdean, A.; Ciurdaru, G. 1994: Antioxidative activity of some vegetal materials. III. Buletinul Universitatii de Stiinte Agricole Cluj-Napoca Seria Zootehnie si Medicina Veterinara 48: 455-458
Madsen, H.-Lindberg; Andersen, L.; Christiansen, L.; Brockhoff, P.; Bertelsen, G. 1996: Antioxidative activity of summer savory (Satureja hortensis L.) and rosemary (Rosmarinus officinalis L.) in minced, cooked pork meat. Zeitschrift fuer Lebensmittel Untersuchung und Forschung 203(4): 333-338
Osawa, T.; Sugiyama, Y.; Inayoshi, M.; Kawakishi, S. 1995: Antioxidative activity of tetrahydrocurcuminoids. Bioscience Biotechnology and Biochemistry 59(9): 1609-1612
Tsuda, T.; Watanabe, M.; Ohshima, K.; Norinobu, S.; Choi, S.W.; Kawakishi, S.; Osawa, T. 1994: Antioxidative activity of the anthocyanin pigments cyanidin 3-O-beta-D-glucoside and cyanidin. Journal of Agricultural and Food Chemistry 42(11): 2407-2410
Kontush, A.; Hübner, C.; Finckh, B.; Kohlschütter, A.; Beisiegel, U. 1995: Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. Biochimica Et Biophysica Acta 1258(2): 177-187
Shaker, E.S.; Ghazy, M.A.; Shibamoto, T. 1995: Antioxidative activity of volatile browning reaction products and related compounds in a hexanal/hexanoic acid system. Journal of Agricultural and Food Chemistry 43(4): 1017-1022
Eiserich, J.P.; Shibamoto, T. 1994: Antioxidative activity of volatile heterocyclic compounds. Journal of Agricultural and Food Chemistry 42(5): 1060-1063
Alaiz, M.; Hidalgo, F.J.; Zamora, R. 1997: Antioxidative activity on nonenzymatically browned proteins produced in oxidized lipid/protein reactions. Journal of Agricultural and Food Chemistry 45(4): 1365-1369
Suzuki, N.; Kanamori, N.; Mashiko, S.; Takasu, Y. 1994: Antioxidative activity with superoxide of oxygen stress relievers, chlorophyll derivatives. Journal of Shimonoseki University of Fisheries 42(2): 81-84
Shiraki, M.; Hara, Y.; Osawa, T.; Kumon, H.; Nakayama, T.; Kawakishi, S. 1994: Antioxidative and antimutagenic effects of theaflavins from black tea. Mutation Research 323(1-2): 29-34
Basaga, H.; Tekkaya, C.; Acikel, F. 1997: Antioxidative and free radical scavenging properties of rosemary extract. Lebensmittel-Wissenschaft and Technologie. 30(1): 105-108
Yen, G.C.; Liu, M.L. 1998: Antioxidative and prooxidative actions of xylose-lysine Maillard reaction products. Bioscience Biotechnology and Biochemistry 62(5): 864-869
Paranich, A.V.; Yukhnyk, O.S. 1993: Antioxidative balance under conditions of total ischemia of isolated organs in rats and protective effect of vitamin E. Fiziologicheskii Zhurnal 39(1): 97-101
Tsuda, T.; Watanabe, M.; Ohshima, K.; Yamamoto, A.; Kawakishi, S.; Osawa, T. 1994: Antioxidative components isolated from the seed of tamarind (Tamarindus indica L.). Journal of Agricultural and Food Chemistry 42(12): 2671-2674
Dusinović, S.; Mijalković, D.; Saicić, Z.S.; Durić, J.; Zunić, Z.; Niketić, V.; Spasić, M.B. 1998: Antioxidative defense in human myocardial reperfusion injury. Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 17(3-4): 281-284
Palic, A.; Dikanovic Lucan, Z. 1995: Antioxidative effect of Herbalox on edible oils. Fett Wissenschaft Technologie 97(10): 379-381
Yoshimura, Y.; IIjima, T.; Watanabe, T.; Nakazawa, H. 1997: Antioxidative effect of Maillard reaction products using glucose-glycine model system. Journal of Agricultural and Food Chemistry 45(10): 4106-4109
Ma, C.L.; Lu, Z.Z.; Jiang, Y.C. 1993: Antioxidative effect of Panax quinquefolium saponin on the myocardium injury induced by doxorubicin in rats. Zhongguo Yaolixue Yu Dulixue Zazhi 7(4): 267-269
Weber, C.; Sejersgård Jakobsen, T.; Mortensen, S.A.; Paulsen, G.; Hølmer, G. 1994: Antioxidative effect of dietary coenzyme Q10 in human blood plasma. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 64(4): 311-315
Isaksen, A.; Adler-Nissen, J. 1997: Antioxidative effect of glucose oxidase and catalase in mayonnaises of different oxidative susceptibility. I. Product trials. Lebensmittel-Wissenschaft und -Technologie 30(8): 841-846
Isaksen, A.; Adler-Nissen, J. 1997: Antioxidative effect of glucose oxidase and catalase in mayonnaises of different oxidative susceptibility. II. Mathematical modelling. Lebensmittel-Wissenschaft und -Technologie 30(8): 847-852
Aimoto, T.; Hirata, M.; Hiraki, Y.; Dote, C.; Inoue, N.; Imai, K. 1994: Antioxidative effect of mammalian liver hydrolyzate on lipid peroxidation. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 114(2): 89-93
Buko, V.; Lukivskaya, O.; Nikitin, V.; Kuryan, A.; Dargel, R. 1997: Antioxidative effect of prostaglandin E2 in thioacetamide-induced liver cirrhosis. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft für Toxikologische Pathologie 49(1-2): 141-146
Imai, K.; Aimoto, T.; Sato, M.; Kimura, R. 1993: Antioxidative effect of protoporphyrin and increase of glutathione in protoporphyrin-administered rat liver. Biological and Pharmaceutical Bulletin 16(8): 759-761
Kim, J.S.; Lee, G.D.; Kwon, J.H.; Yoon, H.S. 1993: Antioxidative effectiveness of ether extract in Crataegus pinnatifida Bunge and Terminalia chebula Rets. Journal of the Korean Agricultural Chemical Society 36(3): 203-207
Yanishlieva, N.V.; Marinova, E.M. 1996: Antioxidative effectiveness of some natural antioxidants in sunflower oil. Zeitschrift für Lebensmittel-Untersuchung und -Forschung 203(3): 220-223
Andersen, H.R.; Nielsen, J.B.; Nielsen, F.; Grandjean, P. 1997: Antioxidative enzyme activities in human erythrocytes. Clinical Chemistry 43(4): 562-568
Rana, S.V.; Kumar, S. 1995: Antioxidative enzyme in the liver of rats after exposure to xylene, toluene and methyl alcohol separately and in combination. Physiological Chemistry and Physics and Medical Nmr 27(1): 25-29
Matyushin, B.N.; Loginov, A.S.; Tkachev, V.D. 1992: Antioxidative enzymes of the liver in its chronic affection. Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya 1992(2): 41-42
Ziprin, Y.A.; Rhee, K.S.; Bravo Gutierrez, L.M.; Osburn, W.N. 1994: Antioxidative fat replacer and high-monounsaturated oil used for pork fat in precooked sausage. Journal of Food Science 59(5): 933-936
Krajcovicovakudlackova, M.; Simoncic, R.; Bederova, A.; Magalova, T.; Grancicova, E.; Klvanova, J. 1996: Antioxidative levels in two nutritional population groups. Oncology Reports 3(6): 1119-1123
Matsuo, M.; Nakamura, N.; Shidoji, Y.; Muto, Y.; Esaki, H.; Osawa, T. 1997: Antioxidative mechanism and apoptosis induction by 3-hydroxyanthranilic acid, an antioxidant in Indonesian food Tempeh, in the human hepatoma-derived cell line, HuH-7. Journal of Nutritional Science and Vitaminology 43(2): 249-259
Fan, C.T.; Su, J.D. 1997: Antioxidative mechanism of isolated components from methanol extract of fruit hulls of Garcinia mongostana L. Journal of the Chinese Agricultural Chemical Society 35(5): 540-551
Sanbongi, C.; Osakabe, N.; Natsume, M.; Takizawa, T.; Gomi, S.; Osawa, T. 1998: Antioxidative polyphenols isolated from Theobroma cacao. Journal of Agricultural and Food Chemistry 46(2): 454-457
Kawaguchi, K.; Satomi, K.; Yokoyama, M.; Ishida, Y. 1996: Antioxidative properties of an extracellular polysaccharide produced by a bacterium Klebsiella sp. isolated from river water. Nippon Suisan Gakkaishi 62(1): 123-128
Yen, G.C.; Lee, C.E. 1997: Antioxidative properties of extracts from Aspergillus candidus broth filtrate. Journal of the Science of Food and Agriculture 75(3): 326-332
Chen, H.M.; Muramoto, K.; Yamauchi, F.; Fujimoto, K.; Nokihara, K. 1998: Antioxidative properties of histidine-containing peptides designed from peptide fragments found in the digests of a soybean protein. Journal of Agricultural and Food Chemistry 46(1): 49-53
Yen, G.C.; Duh, P.D. 1993: Antioxidative properties of methanolic extracts from peanut hulls. Journal Of The American Oil Chemists' Society. 70(4): 383-386
Zbikowska, B.; Sroka, Z.; Rzadkowska-Bodalska, H.; Wisnicka, R. 1996: Antioxidative properties of methanolic extracts from some Euonymus L. species. Bulletin of the Polish Academy of Sciences Biological Sciences 44(1-2): 21-28
Wieslander, E.; Engman, L.; Svensjö, E.; Erlansson, M.; Johansson, U.; Linden, M.; Andersson, C.M.; Brattsand, R. 1998: Antioxidative properties of organotellurium compounds in cell systems. Biochemical Pharmacology 55(5): 573-584
Schneider, I.; Elstner, E.F. 1993: Antioxidative properties of phenazone derivatives: differentiation between phenylbutazon and mofebutazon. Zeitschrift für Naturforschung. C Journal of Biosciences 48(7-8): 542-544
Butow, B., J.; Wynne, D.; Tel-Or, E. 1997: Antioxidative protection of Peridinium gatunense in Lake Kinneret: Seasonal and daily variation. Journal of Phycology 33(5): 780-786
Bilgihan, A.; Bilgihan, M.K.; Akata, R.F.; Aricioğlu, A.; Hasanreisoğlu, B. 1995: Antioxidative role of ocular melanin pigment in the model of lens induced uveitis. Free Radical Biology and Medicine 19(6): 883-885
Sato, M.; Sasaki, M.; Hojo, H. 1995: Antioxidative roles of metallothionein and manganese superoxide dismutase induced by tumor necrosis factor-alpha and interleukin-6. Archives of Biochemistry and Biophysics 316(2): 738-744
Volkovová, K.; Chorváthová, V.; Jurcovicová, M.; Koszeghyová, L.; Bobek, P. 1993: Antioxidative state of the myocardium and kidneys in acute diabetic rats. Physiological Research 42(4): 251-255
de Mecca, M.M.; Castro, G.D.; Castro, J.A. 1993: Antioxidative stress therapy with dithiothreitol tetraacetate. I. Protection against carbon tetrachloride induced liver necrosis. Archives of Toxicology 67(8): 547-551
Gorgaslidze, A.G.; Sumaiya, M.; Esshchanova, F.S.; Golitsyna, L.S.; Smetnev, A.S. 1993: Antioxidative therapy in arrhythmic type of alcoholic damage to the heart. Kardiologiya 33(9): 4, 38-40
Böhles, H. 1997: Antioxidative vitamins in prematurely and maturely born infants. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 67(5): 321-328
Nagel, E.; Meyer zu Vilsendorf, A.; Bartels, M.; Pichlmayr, R. 1997: Antioxidative vitamins in prevention of ischemia/reperfusion injury. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 67(5): 298-306
Lehtinen, P.; Laakso, S. 1997: Antioxidative-like effect of different cereals and cereal fractions in aqueous suspension. Journal of Agricultural and Food Chemistry 45(12): 4606-4611
Rhee, K.S.; Krahl, L.M.; Lucia, L.M.; Acuff, G.R. 1998: Antioxidative/antimicrobial effects and TBARS in aerobically refrigerated beef as related to microbial growth. Journal of Food Science 63(1): 1205-1210
Hons'kyi, Y.I.; Korda, M.M.; Klishch, I.M.; Fira, L.S. 1995: Antioxidizing properties of acetylcysteine. Farmatsevtychnyi Zhurnal (Kiev) 1995(5): 75-76
Semwal, A.D.; Sharma, G.K.; Arya, S.S. 1997: Antioxygenic activity of turmeric (Curcuma longa) in sunflower oil and ghee. Journal of Food Science and Technology (Mysore) 34(1): 67-69
Bocola, V.; Trecco, M.D.; Fabbrini, G.; Paladini, C.; Sollecito, A.; Martucci, N. 1998: Antipanic effect of fluoxetine measured by CO2 challenge test. Biological Psychiatry 43(8): 612-615
Kalisch, B.W.; Germann, M.W.; van de Sande, J.H. 1998: Antiparallel DNA duplex formation between alternating alpha d(GA)n and beta d(GA)n sequences. Febs Letters 427(2): 301-304
Dolfini, S.; Consonni, G.; Mereghetti, M.; Tonelli, C. 1993: Antiparallel expression of the sense and antisense transcripts of maize alpha-tubulin genes. Molecular and General Genetics: Mgg 241(1-2): 161-169
Joseph, J.; Kandala, J.C.; Veerapanane, D.; Weber, K.T.; Guntaka, R.V. 1997: Antiparallel polypurine phosphorothioate oligonucleotides form stable triplexes with the rat alpha1(I) collagen gene promoter and inhibit transcription in cultured rat fibroblasts. Nucleic Acids Research 25(11): 2182-2188
Mrksich, M.; Dervan, P.B. 1993: Antiparallel side-by-side heterodimer for sequence-specific recognition in the minor groove of DNA by a distamycin 1-methylimidazole-2-carboxamide-netropsin pair. Journal of the American Chemical Society 115(7): 2572-2576
Rooney, S.M.; Moore, P.D. 1995: Antiparallel, intramolecular triplex DNA stimulates homologous recombination in human cells. Proceedings of the National Academy of Sciences of the United States of America 92(6): 2141-2144
Ojha, V.; Singh, J.; Bhakuni, D.S.; Singh, S.-Nath; Fatma, N.; Chatterjee, R.K. 1993: Antiparasitic agents: Part XVII. Synthesis of 5-acyl-2-acylamino-1H-benzimidazoles and their macrofilaricidal and chemosterilizing activities. Indian Journal of Chemistry. Sect. B 32(3): 394-398
Lamidi, M.; Gasquet, M.; Ollivier, E.; Ekekang, L.N.; Balansard, G. 1996: Antiparasitic studies of Nauclea diderrichii bark. Pharmaceutical and Pharmacological Letters 6(1): 31-33
Ossowska, K.; Lorenc-Koci, E.; Wolfarth, S. 1994: Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: A mechanomyographic analysis. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 7(2): 143-152
Kaur, S.; Starr, M.S. 1995: Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse. European Journal of Pharmacology 280(2): 159-166
Starr, M.S. 1995: Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 10(2-3): 141-185
Irifune, M.; Nomoto, M.; Fukuda, T. 1994: Antiparkinsonian activity of talipexole in MPTP-treated monkeys: In combination with L-DOPA and as chronic treatment. European Journal of Pharmacology 264(2): 117-123
Schmidt, W.J.; Schuster, G.; Wacker, E.; Pergande, G. 1997: Antiparkinsonian and other motor effects of flupirtine alone and in combination with dopaminergic drugs. European Journal of Pharmacology 327(1): 1-9
Lustig, H.S.; Ahern, K.V.; Greenberg, D.A. 1992: Antiparkinsonian drugs and in vitro excitotoxicity. Brain Research 597(1): 148-150
Urbańska, E.; Dziki, M.; Czuczwar, S.J.; Kleinrok, Z.; Turski, W.A. 1992: Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures. Neuropharmacology 31(10): 1021-1026
Kuno, S.; Mizuta, E.; Sakamoto, H.; Ichihara, K.; Nagasaka, M. 1998: Antiparkinsonian effects of BAM-1110, a novel ergoline derivative, in MPTP-treated cynomolgus monkeys. Clinical Neuropharmacology 21(1): 35-40
Greenamyre, J.T.; Eller, R.V.; Zhang, Z.; Ovadia, A.; Kurlan, R.; Gash, D.M. 1994: Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Annals of Neurology 35(6): 655-661
Zivin, M.; Sprah, L.; Sket, D. 1998: Antiparkinsonian potential of interaction of LEK-8829 with bromocriptine. European Journal of Pharmacology 349(2-3): 151-157
Echeverria, C., A.; Castro, C., B. 1995: Antipathes (Cnidaria, Antipatharia) from southeastern Brazil. Boletim do Museu Nacional, Zoologia 364: 1-8
Mastrogiacomo, A.; Evans, C.J.; Gundersen, C.B. 1994: Antipeptide antibodies against a Torpedo cysteine-string protein. Journal of Neurochemistry 62(3): 873-880
Cribb, A.; Nuss, C.; Wang, R. 1995: Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6. Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(7): 671-675
Wangsgard, W.P.; Dasgupta, M.; Blumenthal, D.K. 1997: Antipeptide antibodies as probes of subunit-dependent structural changes in the regulatory domain of the gamma-subunit of phosphorylase kinase. Biochemical and Biophysical Research Communications 230(1): 179-183
Brüss, M.; Hammermann, R.; Brimijoin, S.; Bönisch, H. 1995: Antipeptide antibodies confirm the topology of the human norepinephrine transporter. Journal of Biological Chemistry 270(16): 9197-9201
Curin-Serbec, V.; Délot, E.; Faure, G.; Saliou, B.; Gubensek, F.; Bon, C.; Choumet, V. 1994: Antipeptide antibodies directed to the C-terminal part of ammodytoxin A react with the PLA2 subunit of crotoxin and neutralize its pharmacological activity. Toxicon: Official Journal of the International Society on Toxinology 32(11): 1337-1348
Laurenzana, E.M.; Sorrels, S.L.; Owens, S.M. 1995: Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6. Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(2): 271-278
Lähdeaho, M.L.; Lehtinen, M.; Rissa, H.R.; Hyöty, H.; Reunala, T.; Mäki, M. 1993: Antipeptide antibodies to adenovirus E1b protein indicate enhanced risk of celiac disease and dermatitis herpetiformis. International Archives of Allergy and Immunology 101(3): 272-276
Scippo, M.L.; Degand, G.; Duyckaerts, A.; Michel, A.; Joris, B.; Delahaut, P.; Decuypere, E.; Maghuin-Rogister, G. 1996: Antipeptide antibody against bovine IGF-BP-2: Application to the detection of bovine somatotropin-treated cows. Food and Agricultural Immunology 8(1): 31-40
Sobel, J.H.; Trakht, I.; Pileggi, N.; Qi Wu, H. 1998: Antipeptide monoclonal antibodies to defined fibrinogen Aalpha chain regions: anti-Aalpha 487-498, a structural probe for fibrinogenolysis. Blood 91(5): 1590-1598
Falcone, M.; Miyamoto, T.; Fierro-Renoy, F.; Macchia, E.; DeGroot, L.J. 1992: Antipeptide polyclonal antibodies specifically recognize each human thyroid hormone receptor isoform. Endocrinology 131(5): 2419-2429
Tishler, M.; Maran, R.; Langevitz, P.; Livneh, A.; Gazit, E.; Gilburd, B.; Youinou, P.; Shoenfeld, Y. 1997: Antiperinuclear factor--clinical, serological and genetic correlates in Israeli patients with rheumatoid arthritis. Rheumatology International 17(4): 141-143
Kerstens, P.J.; Boerbooms, A.M.; Jeurissen, M.E.; Westgeest, T.A.; Van Erp, A.; Mulder, J.; van de Putte, L.B. 1994: Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Journal of Rheumatology 21(12): 2190-2194
Muñoz-Fernández, S.; Alvarez-Doforno, R.; Cuesta, M.; Balsa, A.; Fontán, G.; Gijón-Baños, J. 1995: Antiperinuclear factor: A useful test for the diagnosis of rheumatoid arthritis. Rheumatology International 15(4): 145-149
Berthelot, J.M.; Maugars, Y.; Castagné, A.; Audrain, M.; Prost, A. 1997: Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled. Annals of the Rheumatic Diseases 56(2): 123-125
Yagi, T.; Nakagawa, K.; Sadamori, H.; Hashimoto, M.; Kamikawa, Y.; Tanaka, N. 1997: Antiperistaltic transverse colostomy for massive bowel necrosis following surgery for an abdominal aortic aneurysm: Report of a case. Surgery Today 27(6): 554-558
Yokozawa, T.; Dong, E.; Liu, Z.W.; Oura, H.; Nishioka, I. 1996: Antiperoxidation activity of Wen-Pi-Tang in vitro. Natural Medicines 50(3): 243-246
Yokozawa, T.; Dong, E.; Liu, Z.W.; Oura, H. 1997: Antiperoxidation activity of traditional Chinese prescriptions and their main crude drugs in vitro. Natural Medicines 51(2): 92-97
Reddy, D.S.; Singh, M. 1995: Antiperoxidative effects of platelet activating factor antagonists against iron-dependent lipid peroxidation in murine ventricular membranes. Methods and Findings in Experimental and Clinical Pharmacology 17(6): 383-390
Lavoie, J.C.; Lachance, C.; Chessex, P. 1994: Antiperoxide activity of sodium metabisulfite. A double-edged sword. Biochemical Pharmacology 47(5): 871-876
Hagan, D.B.; Leng, F.J.; Smith, P.M.; Snow, M.; Watson, A. 1997: Antiperspirant compositions based on titanium salts. International Journal Of Cosmetic Science. : 271-280,.
Broecker, W., S.; Peteet, D.; Hajdas, I.; Lin, J.; Clark, E. 1998: Antiphasing between rainfall in Africa's Rift Valley and North America's Great Basin. Quaternary Research (Orlando) 50(1): 12-20
Valentine, J.L.; Mayersohn, M.; Wessinger, W.D.; Arnold, L.W.; Owens, S.M. 1996: Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats. Journal of Pharmacology and Experimental Therapeutics 278(2): 709-716
Valentine, J.L.; Owens, S.M. 1996: Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. Journal of Pharmacology and Experimental Therapeutics 278(2): 717-724
Azzolina, O.; Ghislandi, V. 1993: Antiphlogistic aryloxypropionic acids: configurational study. Farmaco 48(6): 713-724
Boffa, M.C.; Berard, M.; Sugi, T.; McIntyre, J.A. 1996: Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. Journal of Rheumatology 23(8): 1375-1379
Berard, M.; Chantome, R.; Marcelli, A.; Boffa, M.C. 1996: Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. Journal of Rheumatology 23(8): 1369-1374
Jones, J.V.; Eastwood, B.J.; Jones, E.; James, H.; Mansour, M. 1995: Antiphospholipid antibodies in a healthy population: methods for estimating the distribution. Journal of Rheumatology 22(1): 55-61
Meroni, P.L.; Del Papa, N.; Borghi, M.O. 1996: Antiphospholipid and antiendothelial antibodies. International Archives of Allergy and Immunology 111(4): 320-325
Khamashta, M.A.; Hughes, G.R. 1994: Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion. Clinical Reviews in Allergy 12(3): 287-296
Hopkinson, N.P.; Lim, K.; Gardner-Medwin, J. 1994: Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?. Annals of the Rheumatic Diseases 53(9): 619-620
Martini, F.; Farsi, A.; Gori, A.M.; Boddi, M.; Fedi, S.; Domeneghetti, M.P.; Passaleva, A.; Prisco, D.; Abbate, R. 1996: Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus. Lupus 5(3): 206-211
Komatireddy, G.R.; Wang, G.S.; Sharp, G.C.; Hoffman, R.W. 1997: Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. Journal of Rheumatology 24(2): 319-322
Stephansson, E.A.; Niemi, K.M. 1995: Antiphospholipid antibodies and anetoderma: are they associated?. Dermatology 191(3): 204-209
Girmenia, F.; Argentino, C.; Di Scipio, E.; Orzi, F.; Pozzilli, C.; Rasura, M.; Faroni, J.; Valesini, G.; Fieschi, C. 1994: Antiphospholipid antibodies and cerebral artery dissection: Two frequent causes of brain ischemia in young adults. Italian Journal of Neurological Sciences 15(5): 221-227
Aoki, K.; Takeuchi, T.; Abe, T. 1998: Antiphospholipid antibodies and coagulation abnormalities in systemic lupus erythematosus. Journal of Saitama Medical School 25(3): 187-194
Oshiro, B.T.; Silver, R.M.; Scott, J.R.; Yu, H.; Branch, D.W. 1996: Antiphospholipid antibodies and fetal death. Obstetrics and Gynecology 87(4): 489-493
Balasch, J.; Creus, M.; Fábregues, F.; Reverter, J.C.; Carmona, F.; Tàssies, D.; Font, J.; Vanrell, J.A. 1996: Antiphospholipid antibodies and human reproductive failure. Human Reproduction 11(10): 2310-2315
Szczepański, M.; Bauer, A.; Gardas, A.; Duchiński, T. 1998: Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 61(1): 39-44
Boddi, M.; Prisco, D.; Fedi, S.; Cellai, A.P.; Liotta, A.A.; Parretti, E.; Mecacci, F.; Mello, G.; Abbate, R. 1996: Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes. Thrombosis Research 82(3): 207-216
Denis, A.L.; Guido, M.; Adler, R.D.; Bergh, P.A.; Brenner, C.; Scott, R.T. 1997: Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertility and Sterility 67(6): 1084-1090
Kutteh, W.H. 1997: Antiphospholipid antibodies and reproduction. Journal of Reproductive Immunology 35(2): 151-171,. 15
Gleicher, N. 1997: Antiphospholipid antibodies and reproductive failure: what they do and what they do not do; how to, and how not to treat!. Human Reproduction 12(1): 13-16
Branch, D.W. 1998: Antiphospholipid antibodies and reproductive outcome: The current state of affairs. Journal of Reproductive Immunology 38(1): 75-87
Dunn, J.P.; Noorily, S.W.; Petri, M.; Finkelstein, D.; Rosenbaum, J.T.; Jabs, D.A. 1996: Antiphospholipid antibodies and retinal vascular disease. Lupus 5(4): 313-322
Balasch, J.; Creus, M.; Fábregues, F.; Cívico, S.; Reverter, J.C.; Carmona, F.; Tàssies, D.; Vanrell, J.A. 1998: Antiphospholipid antibodies and the outcome of pregnancy after the first in-vitro fertilization and embryo transfer cycle. Human Reproduction 13(5): 1180-1183
Ginsberg, J.S.; Wells, P.S.; Brill-Edwards, P.; Donovan, D.; Moffatt, K.; Johnston, M.; Stevens, P.; Hirsh, J. 1995: Antiphospholipid antibodies and venous thromboembolism. Blood 86(10): 3685-3691
Hörkkö, S.; Miller, E.; Dudl, E.; Reaven, P.; Curtiss, L.K.; Zvaifler, N.J.; Terkeltaub, R.; Pierangeli, S.S.; Branch, D.W.; Palinski, W.; Witztum, J.L. 1996: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. Journal of Clinical Investigation 98(3): 815-825
Biasiolo, A.; Pengo, V. 1993: Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(3): 425-428
Coulam, C.B.; Kaider, B.D.; Kaider, A.S.; Janowicz, P.; Roussev, R.G. 1997: Antiphospholipid antibodies associated with implantation failure after IVF/ET. Journal of Assisted Reproduction and Genetics 14(10): 603-608,.
Oosting, J.D.; Derksen, R.H.; Bobbink, I.W.; Hackeng, T.M.; Bouma, B.N.; de Groot, P.G. 1993: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?. Blood 81(10): 2618-2625
Martinuzzo, M.E.; Maclouf, J.; Carreras, L.O.; Lévy-Toledano, S. 1993: Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thrombosis and Haemostasis 70(4): 667-671
Kontiainen, S.; Miettinen, A.; Seppälä, I.; Verkasalo, M.; Mäenpää, J. 1996: Antiphospholipid antibodies in children. Acta Paediatrica 85(5): 614-615
Kaleli, B.; Kaleli, I.; Aktan, E.; Turan, C.; Akşit, F. 1998: Antiphospholipid antibodies in eclamptic women. Gynecologic and Obstetric Investigation 45(2): 81-84
McIntyre, J.A.; Wagenknecht, D.R.; Faulk, W.P. 1995: Antiphospholipid antibodies in heart transplant recipients. Clinical Cardiology 18(10): 575-580
Marco, P.; Lucas, J.; Alonso, A.; Perez-Vazquez, J.; Fernandez, P.; Victoria, C.; Garcia, M.C.; Calatayud, R. 1995: Antiphospholipid antibodies in infertile women. Treatment with prednisone and AAS during pregnancy. Sangre (Saragossa) 40(5): 389-392
Gattorno, M.; Buoncompagni, A.; Molinari, A.C.; Barbano, G.C.; Morreale, G.; Stalla, F.; Picco, P.; Mori, P.G.; Pistoia, V. 1995: Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. British Journal of Rheumatology 34(9): 873-881
Ravelli, A.; Martini, A.; Burgio, G.R. 1994: Antiphospholipid antibodies in paediatrics. European Journal of Pediatrics 153(7): 472-479
Carreira, P.E.; Montalvo, M.G.; Kaufman, L.D.; Silver, R.M.; Izquierdo, M.; Gomez-Reino, J.J. 1997: Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome. Journal of Rheumatology 24(1): 69-72
Caccavo, D.; Greco, B.; Caradonna, L.; Leandro, G.; Bonomo, L.; Jirillo, E. 1996: Antiphospholipid antibodies in patients with inflammatory bowel disease. Medical Science Research 24(10): 711-713
Kinoshita, I.; Motomura, M.; Nagasato, K.; Ichinose, K.; Ohishi, K.; Takeo, G.; Satoh, A.; Nakamura, T.; Yoshimura, T.; Tsujihata, M.; Nagataki, S. 1994: Antiphospholipid antibodies in patients with myasthenia gravis. Acta Medica Nagasakiensia 39(3): 41-44
Allen, J.Y.; Tapia-Santiago, C.; Kutteh, W.H. 1996: Antiphospholipid antibodies in patients with preeclampsia. American Journal of Reproductive Immunology 36(2): 81-85
Provenzale, J.M.; Heinz, E.R.; Ortel, T.L.; Macik, B.G.; Charles, L.A.; Alberts, M.J. 1994: Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. Radiology 192(2): 531-537
Seaman, D.E.; Londino, A.V.; Kwoh, C.K.; Medsger, T.A.; Manzi, S. 1995: Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96(6): 1040-1045
Glacet-Bernard, A.; Bayani, N.; Chretien, P.; Cochard, C.; Lelong, F.; Coscas, G. 1994: Antiphospholipid antibodies in retinal vascular occlusions. A prospective study of 75 patients. Archives of Ophthalmology 112(6): 790-795
Birdsall, M.A.; Lockwood, G.M.; Ledger, W.L.; Johnson, P.M.; Chamley, L.W. 1996: Antiphospholipid antibodies in women having in-vitro fertilization. Human Reproduction 11(6): 1185-1189
Branch, D.W.; Silver, R.; Pierangeli, S.; van Leeuwen, I.; Harris, E.N. 1997: Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstetrics and Gynecology 89(4): 549-555
Severi, S.; Ghezzi, M.; Felici, M.; Miele, A. 1993: Antiphospholipid antibodies syndrome and cerebral ischemia. Italian Journal of Neurological Sciences 14(2): 129-137
Ina, Y.; Takada, K.; Yamamoto, M.; Sato, T.; Ito, S.; Sato, S. 1994: Antiphospholipid antibodies. a prognostic factor in sarcoidosis?. Chest 105(4): 1179-1183
Provenzale, J.M.; Barboriak, D.P.; Allen, N.B.; Ortel, T.L. 1998: Antiphospholipid antibodies: findings at arteriography. Ajnr. American Journal of Neuroradiology 19(4): 611-616
Nsiri, B.; Ghazouani, E.; Gritli, N.; Mazigh, C.; Bayoudh, F.; Messaoud, T.; Fattoum, S.; Machghoul, S. 1998: Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease. Hematology and Cell Therapy 40(3): 107-112
Stasi, R.; Stipa, E.; Masi, M.; Oliva, F.; Sciarra, A.; Perrotti, A.; Zaccari, G.; Papa, G. 1993: Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Thrombosis and Haemostasis 70(4): 568-572
Sugai, S. 1992: Antiphospholipid antibody and antiphospholipid antibody syndrome. Current Opinion in Rheumatology 4(5): 666-671
McCrae, K.R. 1996: Antiphospholipid antibody associated thrombosis: a consensus for treatment?. Lupus 5(6): 560-570
Obringer, A.R.; Rote, N.S.; Walter, A. 1995: Antiphospholipid antibody binding to bilayer-coated glass microspheres. Journal of Immunological Methods 185(1): 81-93
Yetman, D.L.; Kutteh, W.H. 1996: Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 66(4): 540-546
Kaider, B.D.; Price, D.E.; Roussev, R.G.; Coulam, C.B. 1996: Antiphospholipid antibody prevalence in patients with IVF failure. American Journal of Reproductive Immunology 35(4): 388-393
Grondin, F.; Giannoccaro, J.P. 1995: Antiphospholipid antibody syndrome associated with large aortic valve vegetation and stroke. Canadian Journal of Cardiology 11(2): 133-135
Ruffatti, A.; Aversa, S.; Del Ross, T.; Tonetto, S.; Fiorentino, M.; Todesco, S. 1994: Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome?. Journal of Rheumatology 21(11): 2162-2163
Scott, T.F.; Hess, D.; Brillman, J. 1994: Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging. Archives of Internal Medicine 154(8): 917-920
Kerr, J.E.; Poe, R.; Kramer, Z. 1997: Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 112(6): 1707-1710
Niaz, A.; Butany, J. 1998: Antiphospholipid antibody syndrome with involvement of a bioprosthetic heart valve. Canadian Journal of Cardiology 14(7): 951-954
Vassalluzzo, C.J.; McGee, D.L.; Glynn, M.J. 1995: Antiphospholipid antibody syndrome: An unusual cause of stroke in a 22-year-old female. Journal of Emergency Medicine 13(4): 485-488
Kutteh, W.H. 1996: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. American Journal of Obstetrics and Gynecology 174(5): 1584-1589
Stewart, M.W.; Etches, W.S.; Gordon, P.A. 1997: Antiphospholipid antibody-dependent C5b-9 formation. British Journal of Haematology 96(3): 451-457
Pierangeli, S.S.; Goldsmith, G.H.; Branch, D.W.; Harris, E.N. 1997: Antiphospholipid antibody: Functional specificity for inhibition of prothrombin activation by the prothrombinase complex. British Journal of Haematology 97(4): 768-774
Greaves, M. 1997: Antiphospholipid syndrome. Journal of Clinical Pathology (London) 50(12): 973-974
Bakimer, R.; Blank, M.; Kosashvilli, D.; Ichikawa, K.; Khamashta, M.A.; Hughes, G.R.; Koike, T.; Shoenfeld, Y. 1995: Antiphospholipid syndrome and the idiotypic network. Lupus 4(3): 204-208
Gibson, G.E.; Su, W.P.; Pittelkow, M.R. 1997: Antiphospholipid syndrome and the skin. Journal of the American Academy of Dermatology 36(6 Pt 1): 970-982
Pelletier, S.; Landi, B.; Piette, J.C.; Ekert, P.; Coutellier, A.; Desmoulins, C.; Fadlallah, J.P.; Herson, S.; Valla, D. 1994: Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. Journal of Hepatology 21(1): 76-80
Labarca, J.A.; Rabaggliati, R.M.; Radrigan, F.J.; Rojas, P.P.; Perez, C.M.; Ferrés, M.V.; Acuna, G.G.; Bertin, P.A. 1997: Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 24(2): 197-200
Becker, J.C.; Winkler, B.; Klingert, S.; Broecker, E.B.ttina 1994: Antiphospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer (philadelphia). 73(6): 1621-1624
Chun, W.H.; Bang, D.; Lee, S.K. 1996: Antiphospholipid syndrome associated with progressive systemic sclerosis. Journal of Dermatology 23(5): 347-351
Milstone, A.; Fan, A.; Fuchs, H. 1996: Antiphospholipid syndrome associated with seizures. Southern Medical Journal 89(7): 738-740
Kelion, A.D.; Cockcroft, J.R.; Ritter, J.M. 1995: Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgraduate Medical Journal 71(834): 233-235
Clark, F.L.; Greenwood, P.; Forster, P.J. 1994: Antiphospholipid syndrome in pregnancy: a diagnostic dilemma. Medical Journal of Australia 160(4): 217-218
Whittaker, R.; Barnett, A.; Ryan, P. 1993: Antiphospholipid syndrome in scleroderma. Journal of Rheumatology 20(9): 1598-1600
Piette, J.C.; Cacoub, P. 1998: Antiphospholipid syndrome in the elderly: caution. Circulation 97(22): 2195-2196
Evans, R.E.; Dillon, M.J.; Alfaham, M. 1996: Antiphospholipid syndrome presenting as episodic limb ischaemia. Archives of Disease in Childhood 75(4): 342-343
Harle, J.R.; Disdier, P.; Cherif, A.A.; Swiader, L.; Royere, M.L.; Weiller, P.J. 1992: Antiphospholipid syndrome revealed by memory disorders. Revue Neurologique (Paris) 148(10): 635-637
Galli, M.; Finazzi, G.; Bevers, E., M.; Barbui, T. 1995: Antiphospholipid syndrome: Advances in pathophysiology and treatment. JN Journal of Nephrology 8(4): 185-190
Jedryka-Goral, A.; Chwalinska-Sadowska, H.; Biernat-Kaluza, E.; Meissner, M.; Wojciechowska, B.; Wagner, T. 1998: Antiphospholipid syndrome: An interdisciplinary clinical problem. Reumatologia 36(2): 151-163
Insko, E.K.; Haskal, Z.J. 1997: Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications. Radiology 202(2): 319-326
Bick, R.L. 1997: Antiphospholipid thrombosis syndromes: etiology, pathophysiology, diagnosis and management. International Journal of Hematology 65(3): 193-213
Kamin, G.; Schaefer, M.; Morgenstern, S.; Distler, W. 1998: Antiphospholipid-antibody syndrome. Follow-up observations and therapeutic possibilities within the framework of intensive-care obstetrics. Geburtshilfe und Frauenheilkunde 58(2): 116-120
Coniglio, M.; Platania, A.; Di Nucci, G.D.; Arcieri, P.; Modzrewska, R.; Mariani, G. 1996: Antiphospholipid-protein antibodies are not an uncommon feature in retinal venous occlusions. Thrombosis Research 83(2): 183-188
Jedryka-Goral, A.; Maldykowa, H.; Chwalinska-Sadowska, H.; Wojciechowska, B. 1994: Antiphospholipids syndrome in patients with systemic lupus erythematosus. The clinical importance of aCl antibodies. Reumatologia 32(2): 103-109
Cox, S.; Buontempo, P.J.; Wright-Minogue, J.; DeMartino, J.L.; Skelton, A.M.; Ferrari, E.; Schwartz, J.; Rozhon, E.J.; Linn, C.C.; Girijavallabhan, V.; O'Connell, J.F. 1996: Antipicornavirus activity of SCH 47802 and analogs: In vitro and in vivo studies. Antiviral Research 32(2): 71-79
Diana, G.D.; Cutcliffe, D.; Volkots, D.L.; Mallamo, J.P.; Bailey, T.R.; Vescio, N.; Oglesby, R.C.; Nitz, T.J.; Wetzel, J.; Giranda, V. 1993: Antipicornavirus activity of tetrazole analogues related to disoxaril. Journal of Medicinal Chemistry 36(22): 3240-3250
Diana, G.D.; Pevear, D.C. 1997: Antipicornavirus drugs: Current status. Antiviral Chemistry and Chemotherapy 8(5): 401-408
Mau, M.; Ratner, R.; Gindoff, P. 1994: Antipituitary antibodies in a postpartum woman with partial pituitary deficiency and a normal pituitary MRI scan. Southern Medical Journal 87(2): 267-269
Kjaerheim, V.; Skaare, A.; Barkvoll, P.; Rölla, G. 1996: Antiplaque, antibacterial, and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PVM-MA) copolymer. European Journal of Oral Sciences 104(5-6): 529-534
Jaraki, O.; Strauss, W.E.; Francis, S.; Loscalzo, J.; Stamler, J.S. 1994: Antiplatelet effects of a novel antianginal agent, nicorandil. Journal of Cardiovascular Pharmacology 23(1): 24-30
Kita, Y.; Hirasawa, Y.; Yoshida, K.; Maeda, K. 1994: Antiplatelet activities of FK409, a new spontaneous NO releaser. British Journal of Pharmacology 113(2): 385-388
Goldman, I.L.; Kopelberg, M.; Debaene, J.E.; Schwartz, B.S. 1996: Antiplatelet activity in onion (Allium cepa) is sulfur dependent. Thrombosis and Haemostasis 76(3): 450-452
Rotondo, S.; De Gaetano, G.; Cerletti, C. 1993: Antiplatelet activity of 2-(6-carboxyhexyl)-3-n-hexylcyclohexylamine (IBI P-05006), a thromboxane receptor antagonist. European Journal of Pharmacology 232(1): 41-45
Bertelli, A.A.; Giovannini, L.; Bernini, W.; Migliori, M.; Fregoni, M.; Bavaresco, L.; Bertelli, A. 1996: Antiplatelet activity of cis-resveratrol. Drugs under Experimental and Clinical Research 22(2): 61-63
Lawrence, W.H.; Howell, R.D.; Gollamudi, R. 1994: Antiplatelet activity of nipecotamides in experimental thrombosis in mice. Journal of Pharmaceutical Sciences 83(2): 222-225
Lin, C.N.; Shieh, W.L.; Ko, F.N.; Teng, C.M. 1993: Antiplatelet activity of some prenylflavonoids. Biochemical Pharmacology 45(2): 509-512
Bertelli, A.A.; Giovannini, L.; Giannessi, D.; Migliori, M.; Bernini, W.; Fregoni, M.; Bertelli, A. 1995: Antiplatelet activity of synthetic and natural resveratrol in red wine. International Journal of Tissue Reactions 17(1): 1-3
Schumacher, W.A.; Steinbacher, T.E.; Youssef, S.; Ogletree, M.L. 1992: Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys. Prostaglandins 44(5): 389-397
Gir, S.; Reavis, R.; Turitto, V.T.; Gollamudi, R. 1996: Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor. Biotechnology and Applied Biochemistry 23(1): 63-66
Barry, S.; Mercier, S. 1997: Antiplatelet agents and cardiovascular prevention. Therapie 52(1): 53-58
Al-Khadra, A.S.; Salem, D.N.; Rand, W.M.; Udelson, J.E.; Smith, J.J.; Konstam, M.A. 1998: Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial. Journal of the American College of Cardiology 31(2): 419-425
Tanaka, A.; Sakai, H.; Motoyama, Y.; Ishikawa, T.; Takasugi, H. 1994: Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles. Journal of Medicinal Chemistry 37(8): 1189-1199
Bobbio-Pallavicini, E.; Gugliotta, L.; Centurioni, R.; Porta, C.; Vianelli, N.; Billio, A.; Tacconi, F.; Ascari, E. 1997: Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica 82(4): 429-435
Sener, B.; Deliorman, D.; Ergun, F. 1996: Antiplatelet aggregation potencies of the extracts of Viscum album L. Journal of Faculty of Pharmacy of Gazi University 13(2): 143-146
Teng, C.M.; Lin, C.H.; Kuo, Y.H.; Lin, Y.L.; Huang, T.F. 1994: Antiplatelet and vasorelaxing actions of the acetoxy derivative of cedranediol isolated from Juniperus squamata. Planta Medica 60(3): 209-213
Ulla Anes, M.; Cervera Perez, A.D.; Santos Polo, R. 1997: Antiplatelet and anticoagulant therapy in the thromboembolic disease of lower limbs. Geriatrika 13(6): 29-32
Almony, G.T.; Lefkovits, J.; Topol, E.J. 1996: Antiplatelet and anticoagulant use after myocardial infarction. Clinical Cardiology 19(5): 357-365
Vemulapalli, S.; Watkins, R.W.; Chintala, M.; Davis, H.; Ahn, H.S.; Fawzi, A.; Tulshian, D.; Chiu, P.; Chatterjee, M.; Lin, C.C.; Sybertz, E.J. 1996: Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor. Journal of Cardiovascular Pharmacology 28(6): 862-869
Kaku, S.; Kawasaki, T.; Hisamichi, N.; Sakai, Y.; Taniuchi, Y.; Inagaki, O.; Yano, S.; Suzuki, K.; Terazaki, C.; Masuho, Y.; Satoh, N.; Takenaka, T.; Yanagi, K.; Ohshima, N. 1996: Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys. Thrombosis and Haemostasis 75(4): 679-684
Mousa, S.A.; Bozarth, J.M.; Forsythe, M.S.; Jackson, S.M.; Leamy, A.; Diemer, M.M.; Kapil, R.P.; Knabb, R.M.; Mayo, M.C.; Pierce, S.K. 1994: Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Circulation 89(1): 3-12
Hoffmann, P.; Bernat, A.; Savi, P.; Herbert, J.M. 1997: Antiplatelet and antithrombotic efficacy of SR 121787, a nonpeptide orally active GP IIb/IIIa antagonist, in rabbits: comparison with clopidogrel and aspirin. Journal of Cardiovascular Pharmacology 30(3): 360-366
Chen, S.J.; Wang, M.H.; Chen, I.J. 1996: Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. General Pharmacology 27(4): 629-633
Freedman, John; Wright, J. Fraser; Hornstein, Adriana; Kalovsky, Eva; De Friedberg, Zofia Solomon; Adams, Margaret; Wang, Elaine E.L.; Garvey, M. Bernadette; Blanchette, Victor 1996: Antiplatelet antibody detection in alloimmunized patients with acute leukaemia. Transfusion Science 17(2): 295-302
Lescale, K.B.; Eddleman, K.A.; Cines, D.B.; Samuels, P.; Lesser, M.L.; Mcfarland, J.G.; Bussel, J.B. 1996: Antiplatelet antibody testing in thrombocytopenic pregnant women. American Journal of Obstetrics and Gynecology 174(3): 1014-1018
Szczeklik, A.; Krzanowski, M.; Góra, P.; Radwan, J. 1992: Antiplatelet drugs and generation of thrombin in clotting blood. Blood 80(8): 2006-2011
Kaida, T.; Matsuno, H.; Niwa, M.; Kozawa, O.; Miyata, H.; Uematsu, T. 1997: Antiplatelet effect of FK633, a platelet glycoprotein IIb/IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thrombosis and Haemostasis 77(3): 562-567
Tanaka, T.; Fukuta, Y.; Higashino, R.; Sato, R.; Nomura, Y.; Fukuda, Y.; Ito, S.; Takei, M.; Kurimoto, T.; Tamaki, H. 1998: Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist. European Journal of Pharmacology 357(1): 53-60
Tubaro, E.; Belogi, L.; Mezzadri, C.M. 1996: Antiplatelet effect of a new inhibitor of thromboxane synthase and thromboxane A2 receptors. Arzneimittel-Forschung 46(1): 35-41
de la Cruz, J.P.; Romero, M.M.; Sanchez, P.; Sanchez de la Cuesta, F. 1993: Antiplatelet effect of pentoxifylline in human whole blood. General Pharmacology 24(3): 605-609
Neumann, F.J.; Gawaz, M.; Dickfeld, T.; Wehinger, A.; Walter, H.; Blasini, R.; Schomig, A. 1997: Antiplatelet effect of ticlopidine after coronary stenting. Journal of the American College of Cardiology 29(7): 1515-1519
Chung, M.I.; Gan, K.H.; Lin, C.N.; Ko, F.N.; Teng, C.M. 1993: Antiplatelet effects and vasorelaxing action of some constituents of Formosan plants. Journal of Natural Products 56(6): 929-934
Chirkov, Y.Y.; Naujalis, J.I.; Sage, R.E.; Horowitz, J.D. 1993: Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. Journal of Cardiovascular Pharmacology 21(3): 384-389
Hohlfeld, T.; Scharnowski, F.; Braun, M.; Schrör, K. 1994: Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia. Thrombosis and Haemostasis 71(1): 112-118
Torr-Brown, S.R.; Sobel, B.E. 1996: Antiplatelet effects of urokinase and their clinical implications. Coronary Artery Disease 7(1): 63-68
Mousa, S.A.; Bozarth, J.M.; Forsythe, M.S.; Lorelli, W.; Thoolen, M.J.; Ramachandran, N.; Jackson, S.; De Grado, W.; Reilly, T.M. 1993: Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist. Cardiology 83(5-6): 374-382
Mousa, S.A.; Bozarth, J.M.; Lorelli, W.; Forsythe, M.S.; Thoolen, M.J.; Slee, A.M.; Reilly, T.M.; Friedman, P.A. 1998: Antiplatelet efficacy of XV459, a novel nonpeptide platelet GPIIb/IIIa antagonist: comparative platelet binding profiles with c7E3. Journal of Pharmacology and Experimental Therapeutics 286(3): 1277-1284
Tsai, W.J.; Chen, C.C.; Yu, H.J.; Pan, T.M.; Chen, C.F. 1995: Antiplatelet flavones from Pogostemon cablin. Chinese Pharmaceutical Journal 47(5): 431-436
Nishimura, T.; Yamamoto, T.; Komuro, Y.; Hara, Y. 1995: Antiplatelet functions of a stable prostacyclin analog, SM-10906 are exerted by its inhibitory effect on inositol 1,4,5-trisphosphate production and cytosolic Ca++ increase in rat platelets stimulated by thrombin. Thrombosis Research 79(3): 307-317
Cordiano, I.; Salvan, F.; Randi, M.L.; Ruffatti, M.A.; Steffan, A.; Girolami, A.; Fabris, F. 1996: Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. Journal of Clinical Immunology 16(6): 340-347
Huang, T.F.; Chang, M.C.; Teng, C.M. 1993: Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. Biochimica Et Biophysica Acta 1158(3): 293-299
Liu, S.Y.; Sylvester, D.M. 1994: Antiplatelet structure-activity relationship of tetramethylpyrazine. Life Sciences 55(17): 1317-1326
Zubaid, M.; Penn, I.M.; Buller, C.E.; Moscovich, M.D.; Ricci, D.R.; Chauhan, A. 1997: Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice. Canadian Journal of Cardiology 13(4): 335-340
Collins, R.; Baigent, C.; Sandercock, P.; Peto, R. 1994: Antiplatelet therapy for thromboprophylaxis: The need for careful consideration of the evidence from randomised trials. British Medical Journal 309(6963): 1215-1217
Gonzalez, E.R. 1998: Antiplatelet therapy in atherosclerotic cardiovascular disease. Clinical Therapeutics 20(Suppl): B18-B41
van den Brand, M.J.; Simoons, M.L.; de Boer, M.J.; van Miltenburg, A.; van der Wieken, L.R.; de Feyter, P.J. 1995: Antiplatelet therapy in therapy-resistant unstable angina. A pilot study with REO PRO (c7E3). European Heart Journal 16(Suppl): 36-42
Sivenius, J.; Riekkinen, P.J.; Lowenthal, A.; Smets, P.; Laakso, M. 1993: Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event. Archives of Neurology 50(7): 710-713
Schafer, A.I. 1997: Antiplatelet therapy with glycoprotein IIb/IIIa receptor inhibitors and other novel agents. Texas Heart Institute Journal 24(2): 90-96
Théroux, P. 1997: Antiplatelet therapy: do the new platelet inhibitors add significantly to the clinical benefits of aspirin?. American Heart Journal 134(5 Pt 2): S62-S70
Cohen, A.T.; Skinner, J.A.; Kakkar, V.V. 1994: Antiplatelet treatment for thromboprophylaxis: a step forward or backwards?. BMJ 309(6963): 1213-1215
Sivenius, J.; Riekkinen, P.J.; Laakso, M. 1995: Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes. Bmj 310(6971): 25-26
Pankuch, G.A.; Lichtenberger, C.; Jacobs, M.R.; Appelbaum, P.C. 1996: Antipneumococcal activities of RP 59500 (quinupristin-dalfopristin), penicillin G, erythromycin, and sparfloxacin determined by MIC and rapid time-kill methodologies. Antimicrobial Agents and ChemoTherapy 40(7): 1653-1656
Barry, A.L.; Fuchs, P.C.; Brown, S.D. 1998: Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrobial Agents and ChemoTherapy 42(4): 945-946
Bajaksouzian, S.; Visalli, M.A.; Jacobs, M.R.; Appelbaum, P.C. 1996: Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrobial Agents and ChemoTherapy 40(9): 1973-1976
Pankuch, G.A.; Jacobs, M.R.; Appelbaum, P.C. 1998: Antipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology. Antimicrobial Agents and ChemoTherapy 42(5): 1263-1265
May, E.L.; Aceto, M.D.; Bowman, E.R.; Bentley, C.; Martin, B.R.; Harris, L.S.; Medzihradsky, F.; Mattson, M.V.; Jacobson, A.E. 1994: Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties. Journal of Medicinal Chemistry 37(20): 3408-3418
Ochyra, R. 1993: Antipodal mosses: I. A revision of the genus Holodontium (Seligeriaceae). Fragmenta Floristica et Geobotanica 38(1): 75-98
Ochyra, R. 1994: Antipodal mosses: II. The identity of Ditrichum perporodictyon (Musci, Ditrichaceae). Fragmenta Floristica et Geobotanica 39(1): 113-116
Ochyra, R. 1994: Antipodal mosses: III. Taxonomic status of the genus Monocranum (Dicranaceae). Fragmenta Floristica et Geobotanica 39(2): 453-460
Ochyra, R. 1996: Antipodal mosses: IV. A note on Andreaea hookeri (Andraeaceae). Fragmenta Floristica et Geobotanica 41(1): 287-290
Ochyra, R. 1996: Antipodal mosses: V. On Distichium austro-georgicum (Ditrichaceae). Fragmenta Floristica et Geobotanica 41(1): 335-338
Ochyra, R.; Lewis-Smith, R., I. 1996: Antipodal mosses: VI. Stegonia latifolia (Musci, Pottiaceae) in the Antarctic. Fragmenta Floristica et Geobotanica 41(2): 985-994
Ochyra, R. 1997: Antipodal mosses: VII. A reappraisal of Tortula didymodontoides (Musci, Pottiaceae) from Iles Kerguelen. Fragmenta Floristica et Geobotanica 42(1): 147-152
Pianetti, A.; Salvaggio, L.; Biffi, M.R.; Baffone, W.; Bruscolini, F.; de Donato, S.; Albano, A. 1997: Antipoliomyelitis immunity status in a cohort of young men drafted into military service, residing in the suburban Milan area. European Journal of Epidemiology 13(6): 725-727
Tanzi, M.L.; Colotto, P.; Vignali, M.; Affanni, P.; Bracchi, U.; Bellelli, E. 1997: Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum. European Journal of Epidemiology 13(5): 559-565
Garozzo, A.; Pinizzotto, M.R.; Guerrera, F.; Tempera, G.; Castro, A.; Geremia, E. 1994: Antipoliovirus activity of isothiazole derivatives: Mode of action of 5,5'-diphenyl-3,3'-diisothiazole disulfide (DID). Archives of Virology 135(1-2): 1-11
Misbah, S.A.; Griffiths, H.; Mitchell, T.; Freeland, A.; Haeney, M.R.; Chapel, H.M. 1997: Antipolysaccharide antibodies in 450 children with otitis media. Clinical and Experimental Immunology 109(1): 67-72
Gerencser, G.A.; Ahearn, G.A.; Cattey, M.A. 1996: Antiport-driven sulfate secretion in an invertebrate epithelium. Journal of Experimental Zoology 275(4): 269-276
Larsen, T.; Moldsvor, J. 1992: Antipredator behavior and breeding associations of bar-tailed godwits and whimbrels. Auk 109(3): 601-608
Clark, C.W. 1994: Antipredator behavior and the asset-protection principle. Behavioral Ecology 5(2): 159-170
Blanchard, R.J.; Parmigiani, S.; Bjornson, C.; Masuda, C.; Weiss, S.M.; Blanchard, D.C.roline 1995: Antipredator behavior of Swiss-Webster mice in a visible burrow system. Aggressive Behavior 21(2): 123-136
Heinen, J., T.; Hammond, G. 1997: Antipredator behaviors of newly metamorphosed green frogs (Rana clamitans) and leopard frogs (R. pipiens) in encounters with eastern garter snakes (Thamnophis s. sirtalis). American Midland Naturalist 137(1): 136-144
Wisenden, B.D.; Sargent, R.C.aig 1997: Antipredator behaviour and suppressed aggression by convict cichlids in response to injury-released chemical cues of conspecifics but not to those of an allopatric heterospecific. Ethology 103(4): 283-291
Burger 1998: Antipredator behaviour of hatchling snakes: effects of incubation temperature and simulated predators. Animal Behaviour 56(3): 547-553
Regehr, H.M.; Rodway, M.S.; Montevecchi, W.A. 1998: Antipredator benefits of nest-site selection in Black-legged Kittiwakes. Canadian Journal of Zoology 76(5): 910-915,
Kohlmann, S.G.; Mueller, D.M.; Alkon, P.U. 1996: Antipredator constraints on lactating nubian ibexes. Journal of Mammalogy 77(4): 1122-1131
Van-Alstyne, K., L.; Wylie, C., R.; Paul, V., J. 1994: Antipredator defenses in tropical Pacific soft corals (Coelenterata: Alcyonacea): II. The relative importance of chemical and structural defenses in three species of Sinularia. Journal of Experimental Marine Biology and Ecology 178(1): 17-34
Britson, C.A.; Gutzke, W.H.N. 1993: Antipredator mechanisms of hatchling freshwater turtles. Copeia 2: 435-440
Leal, M.; Rodriguez-Robles, J., A. 1995: Antipredator responses of Anolis cristatellus (Sauria: Polychrotidae). Copeia 1995(1): 155-161
Fitzgibbon, C.D. 1993: Antipredator strategies of female Thomson's gazelles with hidden fawns. Journal of Mammalogy 74(3): 758-762
Lefcort, H.; Eiger, S., M. 1993: Antipredatory behaviour of feverish tadpoles: Implications for pathogen transmission. Behaviour 126(1-2): 13-27
Galetti, M. 1996: Antipredatory behaviours of four primate species in South-East Brazil. Revista Brasileira de Biologia 56(2): 203-209
Tébar, M.; Bellido, C.; Uilenbroek, J.T.; Sánchez-Criado, J.E. 1996: Antiprogestagen RU486 prevents the LH-dependent decrease in the serum concentrations of inhibin in the rat. Cellular and Molecular Neurobiology 16(3): 283-295
D'souza, A.; Hinduja, I.N.; Puri, C.P. 1992: Antiprogestin ZK-98.299 and progesterone display differential binding characteristics in the human myometrial cytosol. Biochimica et Biophysica Acta 1175(1): 73-80
Musgrove, E.A.; Lee, C.S.; Cornish, A.L.; Swarbrick, A.; Sutherland, R.L. 1997: Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Molecular Endocrinology 11(1): 54-66
Jang, G.R.; Benet, L.Z. 1998: Antiprogestin-mediated inactivation of cytochrome P450 3A4. Pharmacology 56(3): 150-157
Li, M.; Spitzer, E.; Zschiesche, W.; Binas, B.; Parczyk, K.; Grosse, R. 1995: Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland. Journal of Cellular Physiology 164(1): 1-8
Fuentealba, B.; Salvatierra, A.M.; Croxatto, H.B. 1994: Anti-progestins and contraception. Advances in Contraception: the Official Journal of the Society for the Advancement of Contraception 10(Suppl 1): 61-68
Koper, J.W.; Molijn, G.J.; van Uffelen, C.J.; Stigter, E.; Lamberts, S.W. 1997: Antiprogestins and iatrogenic glucocorticoid resistance. Life Sciences 60(9): 617-624
Maggi, R.; Pimpinelli, F.; Casulari, L.A.; Piva, F.; Martini, L. 1996: Antiprogestins inhibit the binding of opioids to mu-opioid receptors in nervous membrane preparations. European Journal of Pharmacology 301(1-3): 169-177
Fryer, C.J.; Nordeen, S.K.; Archer, T.K. 1998: Antiprogestins mediate differential effects on glucocorticoid receptor remodeling of chromatin structure. Journal of Biological Chemistry 273(2): 1175-1183
Truss, M.; Bartsch, J.; Beato, M. 1994: Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo. Proceedings of the National Academy of Sciences of the United States of America 91(24): 11333-11337
Toma, S.; Monteghirfo, S.; Tasso, P.; Nicolò, G.; Spadini, N.; Palumbo, R.; Molina, F. 1994: Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines. Cancer Letters 82(2): 209-216
Wang, Y.Z.; Liu, X.Y.; Wu, L.J.; Zhang, Y.B.; Hou, L.; Xu, Q.S. 1997: Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro. Drugs under Experimental and Clinical Research 23(3-4): 97-102
Seledtsov, V.I.; Avdeev, I.V.; Morenkov, A.V.; Seledtsova, G.V.; Kozlov, V.A. 1995: Antiproliferative effect of bone marrow cells on leukemic cells. Immunobiology 192(3-4): 205-217
Cheng, K.; Sawamura, Y.; Sakuma, S.; Tada, M.; Sudo, M.; Aida, T.; Abe, H. 1994: Antiproliferative effect of tumor necrosis factor-alpha on human glioblastoma cells linked with cell cycle arrest in G1 phase. Neurologia Medico-Chirurgica 34(5): 274-278
Peehl, D.M.; Skowronski, R.J.; Leung, G.K.; Wong, S.T.; Stamey, T.A.; Feldman, D. 1994: Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Research 54(3): 805-810
Hoosein, N.M.; Martin, K.J.; Abdul, M.; Logothetis, C.J.; Kaddurah-Daouk, R. 1995: Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells. Anticancer Research 15(4): 1339-1342
Zisterer, D.M.; Hance, N.; Campiani, G.; Garofalo, A.; Nacci, V.; Williams, D.C. 1998: Antiproliferative action of pyrrolobenzoxazepine derivatives in cultured cells: Absence of correlation with binding to the peripheral-type benzodiazepine binding site. Biochemical Pharmacology 55(4): 397-403
Schuster, C.; Chasserot-Golaz, S.; Beck, G. 1993: Antiproliferative action of the steroid RU486 in cultured human lymphoma cells. Cancer Letters 71(1-3): 43-50
Meister, B.; Fink, F.M.; Hittmair, A.; Marth, C.; Widschwendter, M. 1998: Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma. Anticancer Research 18(3a): 1777-1786
Conconi, M.T.; Montesi, F.; Parnigotto, P.P. 1998: Antiproliferative activity and phototoxicity of some methyl derivatives of 5-methoxypsoralen and 5-methoxyangelicin. Pharmacology and Toxicology 82(4): 193-198
Tiozzo, R.; Monti, D.; Straface, E.; Capri, M.; Croce, M.A.; Rainaldi, G.; Franceschi, C.; Malorni, W. 1996: Antiproliferative activity of 3-aminobenzamide in A431 carcinoma cells is associated with a target effect on cytoskeleton. Biochemical and Biophysical Research Communications 225(3): 826-832
Mark, M.D.; Storm, D.R. 1997: Antiproliferative activity of KCl contributes to EGF-induced neurite outgrowth in PC12 cells. Neuroscience Letters 230(2): 73-76
Maignen, F.; Tilleul, P.; Billardon, C.; Xu-Van Opstal, W.Y.; Pélaprat, D.; Elena, P.P.; Denis, P.; Rostène, W. 1996: Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit subconjunctival fibroblasts in an ex-vivo model. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 12(3): 289-298
Maucher, A.; von Angerer, E. 1993: Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumours. Journal of Cancer Research and Clinical Oncology 119(11): 669-674
De Vincenzo, R.; Scambia, G.; Ferlini, C.; Distefano, M.; Filippini, P.; Riva, A.; Bombardelli, E.; Pocar, D.; Gelmi, M.L.; Benedetti Panici, P.; Mancuso, S. 1998: Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines. Anti-Cancer Drug Design 13(1): 19-33
D'Onofrio, C.; Franzese, O.; De Marco, A.; Bonmassar, E.; Amici, C. 1994: Antiproliferative activity of cyclopentenone prostaglandins in early HTLV-1 infection is independent of IL-2 and is associated with HSP70 induction. Leukemia 8(6): 1045-1056
Gilbert, N.E.; O'Reilly, J.E.; Chang, C.J.; Lin, Y.C.; Brueggemeier, R.W. 1995: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sciences 57(1): 61-67
Yamazaki, Y.; Goto, M.; Kobayashi, K.; Ogawa, Y.; Shimura, T.; Oka, S.; Okuno, H. 1994: Antiproliferative activity of haloosmocenium ions against human and murine cancer cell lines. Bioorganic and Medicinal Chemistry Letters 4(3): 483-486
Matarrese, P.; Giandomenico, V.; Fiorucci, G.; Rivabene, R.; Straface, E.; Romeo, G.; Affabris, E.; Malorni, W. 1998: Antiproliferative activity of interferon alpha and retinoic acid in SiHa carcinoma cells: the role of cell adhesion. International Journal of Cancer 76(4): 531-540
Todorov, D.K.; Ninjo, S.S.; Zeller, W.J. 1995: Antiproliferative activity of liposomal epirubicin on experimental human gliomas in vitro and in vivo after intratumoral/interstitial application. Journal of Cancer Research and Clinical Oncology 121(3): 164-168
Kaleagasioglu, F.; Doepner, G.; Biesalski, H.K.; Berger, M.R. 1993: Antiproliferative activity of retinoic acid and some novel retinoid derivatives in breast and colorectal cancer cell lines of human origin. Arzneimittel-Forschung 43(4): 487-490
Kc, S.K.; Mueller, K. 1997: Antiproliferative activity of selected Nepalese medicinal plants against the growth of human keratinocytes. Pharmaceutical and Pharmacological Letters 7(2-3): 63-65
McGuire, T.R.; Kazakoff, P.W.; Hoie, E.B.; Fienhold, M.A. 1996: Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium. PharmacoTherapy 16(2): 237-244
Ferlin, M.G.; Chiarelotto, G.; Marzano, C.; Mobilio, S.; Carlassare, F.; Baccichetti, F. 1995: Antiproliferative activity of some unsubstituted angular analogoues of ellipticine. Farmaco 50(2): 91-98
Liakopoulou-Kyriakides, M.; Stavropoulos, G.; Geromichalos, G.; Papazisis, K.T.; Kortsaris, A.H.; Kyriakidis, D.A. 1998: Antiproliferative activity of synthetic tetrapeptides, analogs of AS-I phytotoxin, towards cancer cell lines. Anti-Cancer Drugs 9(2): 175-179
Brouty-Boye, D.; Kolonias, D.; Lampidis, T.J. 1995: Antiproliferative activity of taxol on human tumor and normal breast cells vs. effects on cardiac cells. International Journal of Cancer 60(4): 571-575
Pizao, P.E.; Smitskamp-Wilms, E.; Van Ark-Otte, J.; Beijnen, J.H.; Peters, G.J.; Pinedo, H.M.; Giaccone, G. 1994: Antiproliferative activity of the topoisomerase I inhibitors topotecan and camptothecin, on sub- and postconfluent tumor cell cultures. Biochemical Pharmacology 48(6): 1145-1154
Katz, A.; Vlodavsky, I.; Davies, M.; Miao, H.Q.; Ben-Sasson, S.A.; Darmon, D.; Hurwitz, H.; Borgel, H.; Benezra, M. 1997: Antiproliferative activity to glomerular mesangial cells and receptor binding of a heparin-mimicking polyaromatic anionic compound. Journal of the American Society of Nephrology: Jasn 8(11): 1688-1697
Benezra, M.; Ben-Sasson, S.A.; Regan, J.; Chang, M.; Bar-Shavit, R.; Vlodavsky, I. 1994: Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 14(12): 1992-1999
Firsching, A.; Nickel, P.; Mora, P.; Allolio, B. 1995: Antiproliferative and angiostatic activity of suramin analogues. Cancer Research 55(21): 4957-4961
Lambert, P.A.; Somers, K.D.; Kohn, E.C.; Perry, R.R. 1997: Antiproliferative and antiinvasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery 122(2): 372-8; Discussion 378-9
Chang, C.J.; Ghosh, P.K.; Hu, Y.F.; Brueggemeier, R.W.; Lin, Y.C. 1993: Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Research Communications in Chemical Pathology and Pharmacology 79(3): 293-312
Guo, N.H.; Krutzsch, H.C.; Inman, J.K.; Shannon, C.S.; Roberts, D.D. 1997: Antiproliferative and antitumor activities of D-reverse peptides derived from the second type-1 repeat of thrombospondin-1. Journal of Peptide Research: Official Journal of the American Peptide Society 50(3): 210-221
Hersh, E.M.; Gschwind, C.R.; Taylor, C.W.; Dorr, R.T.; Taetle, R.; Salmon, S.E. 1992: Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro. Journal of the National Cancer Institute 84(16): 1238-1244
Paterson, J.; Uriel, C.; Egron, M.J.; Herscovici, J.; Antonakis, K.; Alaoui-Jamali, M.A. 1998: Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance. Antimicrobial Agents and ChemoTherapy 42(4): 779-784
Uno, K.; Hirabayashi, H. 1997: Antiproliferative and apoptotic effects of tumor necrosis factor alpha (TNF-alpha) and interferon gamma on cells from squamous cell carcinoma of the head and neck. Dokkyo Journal of Medical Sciences 24(2): 73-81
Miyazawa, K.; Hamano, S.; Ujiie, A. 1996: Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. British Journal of Pharmacology 118(4): 915-922
Borsellino, N.; Crescimanno, M.; Flandina, C.; Leonardi, V.; Rausa, L.; D'Alessandro, N. 1993: Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicin-sensitive and -resistant tumor cell lines. Anti-Cancer Drugs 4(2): 265-272
Sebök, B.; Bonnekoh, B.; Geisel, J.; Mahrle, G. 1994: Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte cultures. European Journal of Pharmacology 270(1): 79-87
Landau, M.; Weizman, A.; Zoref-Shani, E.; Beery, E.; Wasseman, L.; Landau, O.; Gavish, M.; Brenner, S.; Nordenberg, J. 1998: Antiproliferative and differentiating effects of benzodiazepine receptor ligands on B16 melanoma cells. Biochemical Pharmacology 56(8): 1029-1034
Hatzoglou, A.; Bakogeorgou, E.; Hatzoglou, C.; Martin, P.M.; Castanas, E. 1996: Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. European Journal of Pharmacology 310(2-3): 217-223
Klouche, M.; Kirchner, H.; Hölzel, F. 1995: Antiproliferative and recovery effects during treatment of breast and ovarian carcinoma cell cultures with interferon-gamma. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 15(4): 285-289
Letourneur, D.; Logeart, D.; Avramoglou, T.; Jozefonvicz, J. 1993: Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. Journal of Biomaterials Science. Polymer Edition 4(5): 431-444
Ikeda, R.; Nagao, T.; Okabe, H.; Nakano, Y.; Matsunaga, H.; Katano, M.; Mori, M. 1998: Antiproliferative constituents in umbelliferae plants. III. Constituents in the root and the ground part of Anthriscus sylvestris Hoffm. Chemical and Pharmaceutical Bulletin 46(5): 871-874
Ikeda, R.; Nagao, T.; Okabe, H.; Nakano, Y.; Matsunaga, H.; Katano, M.; Mori, M. 1998: Antiproliferative constituents in umbelliferae plants. IV. Constituents in the fruits of Anthriscus sylvestris Hoffm. Chemical and Pharmaceutical Bulletin 46(5): 875-878
Nakano, Y.; Matsunaga, H.; Saita, T.; Mori, M.; Katano, M.; Okabe, H. 1998: Antiproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii. Biological and Pharmaceutical Bulletin 21(3): 257-261
Guh, J.H.; Hwang, T.L.; Ko, F.N.; Chueh, S.C.; Lai, M.K.; Teng, C.M. 1998: Antiproliferative effect in human prostatic smooth muscle cells by nitric oxide donor. Molecular Pharmacology 53(3): 467-474
Guh, J.H.; Yu, S.M.; Ko, F.N.; Wu, T.S.; Teng, C.M. 1996: Antiproliferative effect in rat vascular smooth muscle cells by osthole, isolated from Angelica pubescens. European Journal of Pharmacology 298(2): 191-197
Zhuang, S.H.; Burnstein, K.L. 1998: Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139(3): 1197-1207
Tournaire, R.; Arnaud, S.; Hamedi-Sangsari, F.; Malley, S.; Grange, J.; Blanchet, J.P.; Doré, J.F.; Vila, J. 1994: Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells. Leukemia 8(10): 1703-1707
Alama, A.; Meazza, R.; Barbieri, F.; Biassoni, R.; Mazzei, M.; Nicolin, A. 1993: Antiproliferative effect of DNA polymerase alpha antisense oligodeoxynucleotides on breast cancer cells. Experimental Cell Research 206(2): 318-322
Yablonsky, F.; Nicolas, V.; Riffaud, J.P.; Bellamy, F. 1997: Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. Journal of Urology 157(6): 2381-2387
Murayama, T.; Matsumori, Y.; Iwata, N.; Ito, M.; Taniguchi, T.; Chihara, K.; Matsui, T. 1996: Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022. Japanese Journal of Cancer Research: Gann 87(7): 743-750
Abolhassani, M.; Chiao, J.W. 1995: Antiproliferative effect of a prostatic cell-derived activity on the human androgen-dependent prostatic carcinoma cell line LNCaP. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 15(2): 179-185
Broaddus, W.C.; Chen, Z.J.; Prabhu, S.S.; Loudon, W.G.; Gillies, G.T.; Phillips, L.L.; Fillmore, H. 1997: Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. Neurosurgery 41(4): 908-915
Chenoufi, N.; Drénou, B.; Loréal, O.; Pigeon, C.; Brissot, P.; Lescoat, G. 1998: Antiproliferative effect of deferiprone on the Hep G2 cell line. Biochemical Pharmacology 56(4): 431-437
Urdiales, J.L.; Morata, P.; Núñez De Castro, I.; Sánchez-Jiménez, F. 1996: Antiproliferative effect of dehydrodidemnin B (DDB), A depsipeptide isolated from Mediterranean tunicates. Cancer Letters 102(1-2): 31-37
Porreca, E.; Ucchino, S.; Di Febbo, C.; Di Bartolomeo, N.; Angelucci, D.; Napolitano, A.M.; Mezzetti, A.; Cuccurullo, F. 1994: Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo. Arteriosclerosis and Thrombosis: a Journal of Vascular Biology 14(2): 299-304
Huang, H.C.; Lai, M.W.; Wang, H.R.; Chung, Y.L.; Hsieh, L.M.; Chen, C.C. 1993: Antiproliferative effect of esculetin on vascular smooth muscle cells: Possible roles of signal transduction pathways. European Journal of Pharmacology 237(1): 39-44
Monti, E.; Sinha, B.K. 1994: Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines. Anticancer Research 14(3a): 1221-1226
Kurimoto, M.; Nogami, K.; Ogiichi, T.; Nishijima, M.; Takaku, A. 1995: Antiproliferative effect of multiple autocrine loop blockade in human malignant glioma cell lines. Neurologia Medico-Chirurgica 35(10): 723-727
Hixson, L.J.; Alberts, D.S.; Krutzsch, M.; Einsphar, J.; Brendel, K.; Gross, P.H.; Paranka, N.S.; Baier, M.; Emerson, S.; Pamukcu, R. 1994: Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 3(5): 433-438
Gilhar, A.; Grossman, N.; Kahanovicz, S.; Reuveni, H.; Cohen, S.; Eitan, A. 1996: Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. In vitro and in vivo studies. Acta Dermato-Venereologica 76(6): 437-441
Guerrin, M.; Prats, H.; Mazars, P.; Valette, A. 1992: Antiproliferative effect of phorbol esters on MCF-7 human breast adenocarcinoma cells: relationship with enhanced expression of transforming growth-factor-beta 1. Biochimica et Biophysica Acta 1137(1): 116-120
Sze, S.F.; Ng, T.B.; Liu, W.K. 1993: Antiproliferative effect of pineal indoles on cultured tumor cell lines. Journal of Pineal Research 14(1): 27-33
Isoda, H.; Nakahara, T. 1997: Antiproliferative effect of polyol lipids, 3,5-dihydroxydecanoyl and 5-hydroxy-2-decenoyl esters of arabitol and mannitol on lung cancer cell line A549. Journal of Fermentation and Bioengineering 84(5): 403-406
Florio, C.; Martin, J.G.; Styhler, A.; Heisler, S. 1994: Antiproliferative effect of prostaglandin E2 in cultured guinea pig tracheal smooth muscle cells. American Journal of Physiology 266(2 Pt 1): L131-L137
Araiz, J.J.; Refojo, M.F.; Arroyo, M.H.; Leong, F.L.; Albert, D.M.; Tolentino, F.I. 1993: Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. IOVS Investigative Ophthalmology and Visual Science 34(3): 522-530
Corbeil, J.; Rapaport, E.; Richman, D.D.; Looney, D.J. 1994: Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. Journal of Clinical Investigation 93(5): 1981-1986
Scambia, G.; De Vincenzo, R.; Ranelletti, F.O.; Panici, P.B.; Ferrandina, G.; D'Agostino, G.; Fattorossi, A.; Bombardelli, E.; Mancuso, S. 1996: Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. European Journal of Cancer 32A(5): 877-882
Huber, M.; Poulin, R. 1995: Antiproliferative effect of spermine depletion by N-cyclohexyl-1,3-diaminopropane in human breast cancer cells. Cancer Research 55(4): 934-943
Zielke, A.; Wong, M.G.; Siperstein, A.E.; Clark, O.H.; Rothmund, M.; Duh, Q.Y. 1997: Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells. Journal of Surgical Oncology 66(1): 11-18
Mgbonyebi, O.P.; Russo, J.; Russo, I.H. 1998: Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. International Journal of Oncology 12(4): 865-869
Valín, A.; García-Ocaña, A.; De Miguel, F.; Sarasa, J.L.; Esbrit, P. 1997: Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells. Journal of Cellular Physiology 170(2): 209-215
Tanaka, M.; Yano, S.; Hasegawa, Y.; Nakao, K. 1994: Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor. Arzneimittel-Forschung 44(6): 774-778
Gariboldi, M.B.; Lucchi, S.; Caserini, C.; Supino, R.; Oliva, C.; Monti, E. 1998: Antiproliferative effect of the piperidine nitroxide tempol on neoplastic and nonneoplastic mammalian cell lines. Free Radical Biology and Medicine 24(6): 913-923
Gembitsky, D.S.; Reichelt, K.L.; Elgjo, K. 1998: Antiproliferative effect of the tripeptide pyroGlu-Phe-GlyNH2 on murine melanocytes: transitory delay of cell growth in vitro and the cell cycle specificity. Experimental Cell Research 243(2): 367-374
Piontek, M.; Hengels, K.J.; Porschen, R.; Strohmeyer, G. 1993: Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Research 13(6a): 2119-2123
Carpinelli, P.; Granata, F.; Augusti-Tocco, G.; Rossi, M.; Bartolucci, S. 1993: Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines. Anti-Cancer Drugs 4(6): 629-635
Mcelwain, M.C.; Dettelbach, M.A.; Modzelewski, R.A.; Russell, D.M.; Uskokovic, M.R.; Smith, D.C.; Trump, D.L.; Johnson, C.S. 1995: Antiproliferative effects in vitro and in vivo of 1,25-dihydroxyvitamin D-3 and a vitamin D-3 analog in a squamous cell carcinoma model system. Molecular and Cellular Differentiation 3(1): 31-50
Yu, S.M.; Cheng, Z.J.; Kuo, S.C. 1995: Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat. British Journal of Pharmacology 114(6): 1227-1235
Mallat, A.; Fouassier, L.; Préaux, A.M.; Mavier, P.; Lotersztajn, S. 1995: Antiproliferative effects of ET-1 in human liver Ito cells: an ETB- and a cyclic AMP-mediated pathway. Journal of Cardiovascular Pharmacology 26(Suppl): S132-S134
Aizencang, G.; Harari, P.; Buldain, G.; Guerra, L.; Pickart, M.; Hernandez, P.; Frydman, B. 1998: Antiproliferative effects of N1,N4-dibenzylputrescine in human and rodent tumor cells. Cellular and Molecular Biology 44(4): 615-625
Labit-Le Bouteiller, C.; Jamme, M.F.; David, M.; Silve, S.; Lanau, C.; Dhers, C.; Picard, C.; Rahier, A.; Taton, M.; Loison, G.; Caput, D.; Ferrara, P.; Lupker, J. 1998: Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step. European Journal of Biochemistry 256(2): 342-349
Ebbecke, M.; Unterberg, C.; Buchwald, A.; Stöhr, S.; Wiegand, V. 1992: Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells. Basic Research in Cardiology 87(6): 585-591
Bergé, J.P.; Bourgougnon, N.; Carbonnelle, D.; Le Bert, V.; Tomasoni, C.; Durand, P.; Roussakis, C. 1997: Antiproliferative effects of an organic extract from the marine diatom Skeletonema costatum (Grev.) Cleve. Against a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6). Anticancer Research 17(3c): 2115-2120
Agbaria, R.; Kelley, J.A.; Jackman, J.; Viola, J.J.; Ram, Z.; Oldfield, E.; Johns, D.G. 1997: Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells. Oncology Research 9(3): 111-118
Shahabi, N.A.; Sharp, B.M. 1995: Antiproliferative effects of delta opioids on highly purified CD4+ and CD8+ murine T cells. Journal of Pharmacology and Experimental Therapeutics 273(3): 1105-1113
Corbeil, J.; Richman, D.D.; Wrasidlo, W.; Nicolaou, K.C.; Looney, D.J. 1994: Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells. Cancer Research 54(16): 4270-4273
Buszello, H. 1995: Antiproliferative effects of four different cytokines on renal carcinoma cell lines. Anticancer Research 15(3): 735-738
Cavari, S.; Ruggiero, M.; Vannucchi, S. 1993: Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts. Cell Biology International 17(8): 781-786
Spencer, F.; Chi, L.; Zhu, M.X. 1998: Antiproliferative effects of inducible nitric oxide synthase inhibition on decidualization in pseudopregnant rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 218(1): 45-50
Park, M.H.; Wolff, E.C.; Lee, Y.B.; Folk, J.E. 1994: Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of Chinese hamster ovary cells by guanyl diamines. Journal of Biological Chemistry 269(45): 27827-27832
Rosewicz, S.; Weder, M.; Kaiser, A.; Riecken, E.O. 1996: Antiproliferative effects of interferon alpha on human pancreatic carcinoma cell lines are associated with differential regulation of protein kinase C isoenzymes. Gut 39(2): 255-261
Klouche, M.; Kirchner, H.; Hölzel, F. 1994: Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures. Journal of Cancer Research and Clinical Oncology 120(12): 700-706
Izquierdo, M.A.; Degen, D.; Sypek, J.P.; Von Hoff, D.D. 1996: Antiproliferative effects of interleukin-12 treatment on human tumor colony-forming units taken directly from patients. Anti-Cancer Drugs 7(3): 275-280
Yanagihara, K.; Ito, A.; Toge, T.; Numoto, M. 1993: Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Research 53(23): 5815-5821
Kim, S.; Korhonen, M.; Wilborn, W.; Foldesy, R.; Snipes, W.; Hodgen, G.D.; Anderson, F.D. 1996: Antiproliferative effects of low-dose micronized progesterone. Fertility and Sterility 65(2): 323-331
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop. Cancer Research 54(15): 4091-4095
Reinecke, P.; Corvin, J.; Gabbert, H.E.; Gerharz, C.D. 1997: Antiproliferative effects of paclitaxel (Taxol) on human renal clear cell carcinomas in vitro. European Journal of Cancer 33(7): 1122-1129
Soda, H.; Raymond, E.; Sharma, S.; Lawrence, R.; Cerna, C.; Gomez, L.; Timony, G.A.; Von Hoff, D.D.; Izbicka, E. 1998: Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anti-Cancer Drugs 9(4): 327-331
Fagot, D.; Buquet-Fagot, C.; Lallemand, F.; Mester, J. 1994: Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines. Anti-Cancer Drugs 5(5): 548-556
Bai, L.; Naomoto, Y.; Miyazaki, M.; Orita, K.; Namba, M. 1992: Antiproliferative effects of suramin on human cancer cells in vitro and in vivo. Acta Medica Okayama 46(6): 457-463
Louvet, C.; Djelloul, S.; Forgue-Lafitte, M.E.; Mester, J.; Zimber, A.; Gespach, C. 1996: Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha. British Journal of Cancer 74(3): 394-399
Kobayashi, S.; Mimura, Y.; Notoya, K.; Kimura, I.; Kimura, M. 1992: Antiproliferative effects of the traditional Chinese medicine shimotsu-to, its component cnidium rhizome and derived compounds on primary cultures of mouse aorta smooth muscle cells. Japanese Journal of Pharmacology 60(4): 397-401
Sion-Vardy, N.; Vardy, D.; Rodeck, U.; Kari, C.; Levin, R.M.; Malkowicz, S.B. 1995: Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells. Journal of Surgical Research 59(6): 675-680
Ganjam, L.S.; Thornton, W.H.; Marshall, R.T.; MacDonald, R.S. 1997: Antiproliferative effects of yogurt fractions obtained by membrane dialysis on cultured mammalian intestinal cells. Journal of Dairy Science 80(10): 2325-2329
Hao, X.; Tang, P.; Wang, B. 1996: Antiproliferative effects on Ph+ leukemic cells transfected with antisense bcr/abl fusion gene. Zhonghua Zhong Liu Za Zhi 18(6): 422-425
Mac Neil, S.; Dawson, R.A.; Crocker, G.; Tucker, W.F.; Bittiner, B.; Singleton, J.G.; Hunter, T.; Tierney, D.F. 1993: Antiproliferative effects on keratinocytes of a range of clinically used drugs with calmodulin antagonist activity. British Journal of Dermatology 128(2): 143-150
Nishiura, Y.; Nakamura, T.; Ichinose, K.; Nagasato, K.; Ohishi, K.; Watanabe, H.; Shirabe, S.; Tsujihata, M.; Nagataki, S. 1994: Antiproliferative factor against the human glioblastoma cell line T98G identified in culture supernatants of CD4+ cells from patients with HTLV-I-associated myelopathy. Journal of the Neurological Sciences 122(2): 214-219
Baldwin, G.S. 1994: Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. Proceedings of the National Academy of Sciences of the United States of America 91(16): 7593-7597
Corjay, M.H.; Kearney, M.A.; Munzer, D.A.; Diamond, S.M.; Stoltenborg, J.K. 1998: Antiproliferative gene BTG1 is highly expressed in apoptotic cells in macrophage-rich areas of advanced lesions in Watanabe heritable hyperlipidemic rabbit and human. Laboratory Investigation; A Journal of Technical Methods and Pathology 78(7): 847-858
Saito, T.; Okadome, M.; Sugihara, K.; Sano, M.; Kamura, T.; Nakano, H. 1994: Antiproliferative lymphokine production by human peripheral blood lymphocytes and lymph node lymphocytes detected by a modified double layer soft agarose clonogenic assay. Lymphokine and Cytokine Research 13(1): 55-62
Panda, D.; DeLuca, K.; Williams, D.; Jordan, M.A.; Wilson, L. 1998: Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends. Proceedings of the National Academy of Sciences of the United States of America 95(16): 9313-9318
Senni, K.; Borchiellini, C.; Duchesnay, A.; Pellat, B.; Letourneur, D.; Kern, P. 1998: Antiproliferative polysaccharides modulate distribution and phenotypic expression of collagens by gingival fibroblasts. Journal of Biomedical Materials Research 40(1): 164-169
Kuo, S.M. 1996: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Letters 110(1-2): 41-48
Fulda, S.; Honer, M.; Menke-Moellers, I.; Berthold, F. 1995: Antiproliferative potential of cytostatic drugs on neuroblastoma cells in vitro. European Journal of Cancer 31a(4): 616-621
Bergeron, R.J.; McManis, J.S.; Liu, C.Z.; Feng, Y.; Weimar, W.R.; Luchetta, G.R.; Wu, Q.; Ortiz-Ocasio, J.; Vinson, J.R.; Kramer, D. 1994: Antiproliferative properties of polyamine analogues: a structure-activity study. Journal of Medicinal Chemistry 37(21): 3464-3476
Luo, X.; Sawadogo, M. 1996: Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proceedings of the National Academy of Sciences of the United States of America 93(3): 1308-1313
Garg, H.G.; Joseph, P.A.; Yoshida, K.; Thompson, B.T.; Hales, C.A. 1996: Antiproliferative role of 3-O-sulfate glucosamine in heparin on cultured pulmonary artery smooth muscle cells. Biochemical and Biophysical Research Communications 224(2): 468-473
Saiardi, A.; Bozzi, Y.; Baik, J.H.; Borrelli, E. 1997: Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 19(1): 115-126
Carotenuto, A.; Fattorusso, E.; Lanzotti, V.; Magno, S.; Carnuccio, R.; Iuvone, T. 1998: Antiproliferative sesterterpenes from the Caribbean sponge Cacospongia cf. linteiformis. Comparative Biochemistry and Physiology. Part C Pharmacology Toxicology and Endocrinology 119(2): 119-123
Schmidbauer, J.M.; Hoeh, H.; Jaehnig, T.; Daberkow, I. 1996: Antiproliferative therapy in erbium laser sclerostomy ab externo using 5-fluorouracil. Ophthalmologe 93(5): 569-575
Semba, M.; Honda, I.; Shibagaki, M.; Nishi, Y. 1993: Antipromoting effects of 5-lipoxygenase inhibitors, 3-nitro-2,4,6- trihydroxybenzamide derivatives, on TPA-promoted transformation in BALB 3T3 cells. Cancer Letters 71(1-3): 57-60
Streit, V.; Wiedow, O.; Bartels, J.; Christophers, E. 1995: Antiprotease activity in urine of patients with inflammatory skin disorders. Journal of Investigative Dermatology 105(4): 562-566
Oyedapo, O.O.; Famurewa, A.J. 1995: Antiprotease and Membrane Stabilizing Activities of Extracts of Fagara zanthoxyloides, Olax subscorpioides and Tetrapleura tetraptera. International Journal of Pharmacognosy 33(1): 65-69
Koyama, S.; Rennard, S.I.; Leikauf, G.D.; Ertl, R.F.; Robbins, R.A. 1996: Antiproteases attenuate the release of neutrophil chemotactic activity from bronchial epithelial cells induced by smoke. Experimental Lung Research 22(1): 1-19
Vogelmeier, C.; Buhl, R. 1993: Antiproteases in cystic fibrosis. Atemwegs- und Lungenkrankheiten 19(6): 246-251
Koyama, S.; Rennard, S.I.; Claassen, L.; Robbins, R.A. 1995: Antiproteases modulate bronchial epithelial cell responses to endotoxin. American Journal of Pathology 146(5): 1207-1219
Matsuo, Y.; Takagawa, I.; Koshida, H.; Kawabata, T.; Nakamura, M.; Ida, T.; Zhou, L.; Marumo, F. 1995: Antiproteinuric effect of a thromboxane receptor antagonist, on S-1452, rat diabetic nephropathy and murine lupus nephritis. Pharmacology (Basel) 50(1): 1-8
Gansevoort, R.T.; Sluiter, W.J.; Hemmelder, M.H.; de Zeeuw, D.; de Jong, P.E. 1995: Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 10(11): 1963-1974
Desassis, J.F.; Raats, C.J.; Bakker, M.A.; van den Born, J.; Berden, J.H. 1997: Antiproteinuric effect of ciclosporin a in adriamycin nephropathy in rats. Nephron 75(3): 336-341
Wapstra, F.H.; Van Goor, H.; Navis, G.; De Jong, P.E.; De Zeeuw, D. 1996: Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis. Clinical Science 90(5): 393-401
Wilimowska-Pelc, A.; Stachowiak, D.; Gładysz, M.; Olichwier, Z.; Polanowski, A. 1996: Antiproteolytic activity of goose pancreas: purification, inhibitory properties and amino-acid sequence of a Kazal type trypsin inhibitor. Acta Biochimica Polonica 43(3): 489-496
Katiyar, S.K.; Gordon, V.R.; Mclaughlin, G.L.; Edlind, T.D. 1994: Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Antimicrobial Agents and Chemotherapy 38(9): 2086-2090
Rojavin, M.A.; Cowan, A.; Radzievsky, A.A.; Ziskin, M.C. 1998: Antipruritic effect of millimeter waves in mice: evidence for opioid involvement. Life Sciences 63(18): PL251-PL257
Teofoli, P.; De Pita, O.; Frezzolini, A.; Lotti, T. 1998: Antipruritic effect of oral cyclosporin A in essential senile pruritus. ActaDermato-Venereologica 78(3): 232
Müller, K. 1997: Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals. Biochemical Pharmacology 53(9): 1215-1221
Müller, K.; Gürster, D.; Piwek, S.; Wiegrebe, W. 1993: Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase. Journal of Medicinal Chemistry 36(25): 4099-4107
Müller, K.; Prinz, H. 1997: Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids. Journal of Medicinal Chemistry 40(17): 2780-2787
Müller, K.; Huang, H.S.; Wiegrebe, W. 1996: Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis. Journal of Medicinal Chemistry 39(16): 3132-3138
Müller, K. 1996: Antipsoriatic anthrones: Aspects of oxygen radical formation, challenges and prospects. General Pharmacology 27(8): 1325-1335
Altmeyer, P.J.; Matthes, U.; Pawlak, F.; Hoffmann, K.; Frosch, P.J.; Ruppert, P.; Wassilew, S.W.; Horn, T.; Kreysel, H.W.; Lutz, G. 1994: Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. Journal of the American Academy of Dermatology 30(6): 977-981
Tohen, M.; Zarate, C.A. 1998: Antipsychotic agents and bipolar disorder. Journal of Clinical Psychiatry 59(Suppl): 38-48
Corbett, R.; Camacho, F.; Woods, A.T.; Kerman, L.L.; Fishkin, R.J.; Brooks, K.; Dunn, R.W. 1995: Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120(1): 67-74
Bhavnani, S.M.; Levin, G.M. 1996: Antipsychotic agents: a survey of the prevalence, severity and burden of side effects. International Clinical Psychopharmacology 11(1): 1-12
Blin, O.; Azorin, J.M.; Bouhours, P. 1996: Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients. Journal of Clinical Psychopharmacology 16(1): 38-44
Janicak, P.G.; Davis, J.M. 1996: Antipsychotic dosing strategies in acute schizophrenia. International Clinical Psychopharmacology 11(Suppl): 35-40
Blake, T.J.; Tillery, C.E.; Reynolds, G.P. 1998: Antipsychotic drug affinities at alpha2-adrenoceptor subtypes in post-mortem human brain. Journal of Psychopharmacology 12(2): 151-154
Lidsky, T.I.; Yablonsky-Alter, E.; Zuck, L.G.; Banerjee, S.P. 1997: Antipsychotic drug effects on glutamatergic activity. Brain Research 764(1-2): 46-52
Reynolds, G.P. 1994: Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia. Acta Psychiatrica Scandinavica. Supplementum 380: 36-40
Raschetti, R.; Spila Alegiani, S.; Diana, G.; Da Cas, R.; Traversa, G.; Pasquini, P. 1993: Antipsychotic drug prescription in general practice in Italy. Acta Psychiatrica Scandinavica 87(5): 317-321
McCoy, L.; Cox, C.; Richfield, E.K. 1998: Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression. Synapse 28(3): 195-207
Dorevitch, A.; Meretyk, I.; Umansky, Y.; Galili-Weisstub, E. 1995: Antipsychotic drugs and tardive dyskinesia: Preliminary results in an adolescent psychiatric ward. Journal of Clinical Pharmacy and Therapeutics 20(2): 63-65
Sczekan, S.R.; Strumwasser, F. 1996: Antipsychotic drugs block IP3-dependent Ca(2+)-release from rat brain microsomes. Biological Psychiatry 40(6): 497-502
Connelly, P.J. 1993: Antipsychotic drugs in continuing care: A 2-year follow-up audit. International Journal of Geriatric Psychiatry 8(3): 261-264
Deutch, A.Y.; Ongür, D.; Duman, R.S. 1995: Antipsychotic drugs induce fos protein in the thalamic paraventricular nucleus: A novel locus of antipsychotic drug action. Neuroscience 66(2): 337-346
Lindström, E.; Widerlöv, B.; von Knorring, L. 1996: Antipsychotic drug--a study of the prescription pattern in a total sample of patients with a schizophrenic syndrome in one catchment area in the county of Uppland, Sweden, in 1991. International Clinical Psychopharmacology 11(4): 241-246
Meise, U.; Kurz, M.; Fleischhacker, W.W. 1994: Antipsychotic maintenance treatment of schizophrenia patients: is there a consensus?. Schizophrenia Bulletin 20(1): 215-225
Taiminen, T.J.; Kujari, H. 1994: Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. A controlled retrospective study. Acta Psychiatrica Scandinavica 90(4): 247-251
Gralton, E.J.; James, D.H.; Lindsey, M.P. 1998: Antipsychotic medication, psychiatric diagnosis and children with intellectual disability: A 12-year follow-up study. Journal of Intellectual Disability Research: Jidr 42: 49-57
Findling, R.L.; Grcevich, S.J.; Lopez, I.; Schulz, S.C. 1996: Antipsychotic medications in children and adolescents. Journal of Clinical Psychiatry 57(Suppl): 19-23
Kalish, S.C.; Bohn, R.L.; Mogun, H.; Glynn, R.J.; Gurwitz, J.H.; Avorn, J. 1995: Antipsychotic prescribing patterns and the treatment of extrapyramidal symptoms in older people. Journal of the American Geriatrics Society 43(9): 967-973
Lahti, A.C.; Weiler, M.A.; Corey, P.K.; Lahti, R.A.; Carlsson, A.; Tamminga, C.A. 1998: Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry 43(1): 2-11
D'souza, U.; Mcguffin, P.; Buckland, P.R. 1997: Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. Neuropharmacology 36(11-12): 1689-1696,.-.
Ritter, L.M.; Meador-Woodruff, J.H. 1997: Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression. Biological Psychiatry 42(3): 155-164
Gelenberg, A.J.; Hopkins, H.S. 1996: Antipsychotics in bipolar disorder. Journal of Clinical Psychiatry 57(Suppl): 49-52
Griffon, N.; Pilon, C.; Sautel, F.; Schwartz, J.C.; Sokoloff, P. 1996: Antipsychotics with inverse agonist activity at the dopamine D3 receptor. Journal of Neural Transmission 103(10): 1163-1175
Szreder, Z. 1993: Antipyresis as a result of alpha-1 adrenoceptor blockade. General Pharmacology 24(2): 455-460
Bock, M.; Roth, J.; Kluger, M.J.; Zeisberger, E. 1994: Antipyresis caused by stimulation of vasopressinergic neurons and intraseptal and systemic infusions of gamma-MSH. American Journal of Physiology 266(2 Part 2): R614-R621
Kurokawa, M.; Kumeda, C.A.; Yamamura, J.; Kamiyama, T.; Shiraki, K. 1998: Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice. European Journal of Pharmacology 348(1): 45-51
Tereshchenko, O.S.; Gulevskii, A.K.; Zagnoiko, V.I. 1994: Antipyretic and antiinflammatory action of the low molecular fractions of 1-10 kD isolated from the tissue of the hibernating and cold-adapted animals. Problemy Kriobiologii 1994(4): 23-27
Reymond, D.; Birrer, P.; Lüthy, A.R.; Rimensberger, P.C.; Beck, M.N. 1997: Antipyretic effect of parenteral paracetamol (propacetamol) in pediatric oncologic patients: a randomized trial. Pediatric Hematology and Oncology 14(1): 51-57
Schnaiderman, D.; Lahat, E.; Sheefer, T.; Aladjem, M. 1993: Antipyretic effectiveness of acetaminophen in febrile seizures: Ongoing prophylaxis versus sporadic usage. European Journal of Pediatrics 152(9): 747-749
Van Esch, A.; Van Steensel-Moll, H.A.; Steyerberg, E.W.; Offringa, M.; Habbema, J.D.; Derksen-Lubsen, G. 1995: Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Archives of Pediatrics and Adolescent Medicine 149(6): 632-637
Vauzelle-Kervroëdan, F.; Revzani, Y.; Pons, G.; Consten, L.; Pariente-Khayat, A.; d'Athis, P.; Olive, G. 1996: Antipyretic efficacy of tiaprofenic acid in febrile children. Fundamental and Clinical Pharmacology 10(1): 56-59
Huang, Q.H.; Entwistle, M.L.; Alvaro, J.D.; Duman, R.S.; Hruby, V.J.; Tatro, J.B. 1997: Antipyretic role of endogenous melanocortins mediated by central melanocortin receptors during endotoxin-induced fever. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(9): 3343-3351
Riedel, W. 1997: Antipyretic role of nitric oxide during endotoxin-induced fever in rabbits. International Journal of Tissue Reactions 19(3-4): 171-178
Efthivoulou, M.A.; Berry, M.N. 1997: Antipyrine and aminopyrine induce acetaldehyde accumulation from ethanol in isolated hepatocytes. Alcoholism Clinical and Experimental Research 21(2): 267-274
Engel, G.; Hofmann, U.; Heidemann, H.; Cosme, J.; Eichelbaum, M. 1996: Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clinical Pharmacology and Therapeutics 59(6): 613-623
Ali, H.A.; El-Yazigi, A.; Sieck, J.O.; Ali, M.A.; Dossing, M.; Raines, D.A.; Saour, J.; Ernst, P.; Khan, B. 1995: Antipyrine clearance and metabolite excretion in Saudi patients with non-alcoholic chronic liver disease. Annals of Saudi Medicine 15(5): 473-477
Ali, H.A.; el-Yazigi, A.; Sieck, J.O.; Ali, M.A.; Raines, D.A.; Saour, J.; Ernst, P.; Khan, B.; Døssing, M. 1995: Antipyrine clearance and metabolite excretion in patients with chronic hepatitis C. Journal of Hepatology 22(1): 17-21
Coverdale, S.; Byth, K.; Field, J.; Liddle, C.; Lin, R.; Farrell, G.C. 1995: Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Hepatology 22(4 Pt 1): 1065-1071
Grieco, A.; Castellano, R.; Matera, A.; Marcoccia, S.; Di Rocco, P.; Ragazzoni, E.; Vecchio, F.M.; Gasbarrini, G. 1998: Antipyrine clearance in chronic and neoplastic liver diseases: A study of 518 patients. Journal of Gastroenterology and Hepatology 13(5): 460-466
Jorquera, F.; Almar, M.; Martinez, C.; Gonzalez-Sastre, M.; Culebras, J.M.; Gonzalez-Gallego, J. 1994: Antipyrine clearance in surgical patients maintained on hypocaloric peripheral parenteral nutrition. Jpen. Journal of Parenteral and Enteral Nutrition 18(6): 544-548
Kurata, N.; Inagaki, M.; Kobayashi, S.; Nishimura, Y.; Oguchi, K.; Yasuhara, H. 1993: Antipyrine concentrations in liver and blood monitored by microdialysis of unrestrained conscious rats. Research Communications in Chemical Pathology and Pharmacology 79(3): 363-369
Tripathi, M.; Verma, M.; Palit, G.; Shanker, K. 1993: Antipyrine congeners as antidepressant agents. Arzneimittel-Forschung 43(10): 1045-1049
Caraco, Y.; Zylber-Katz, E.; Berry, E.M.; Levy, M. 1995: Antipyrine disposition in obesity: Evidence for negligible effect of obesity on hepatic oxidative metabolism. European Journal of Clinical Pharmacology 47(6): 525-530
Wensing, G.; Hoffmann, K.; Heidemann, H.T. 1993: Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis. Zeitschrift für Gastroenterologie 31(1): 15-19
Von Moltke, L.L.; Abernethy, D.R.; Kaplan, M.M.; Greenblatt, D.J. 1993: Antipyrine kinetics in patients with primary biliary cirrhosis. Journal of Clinical Pharmacology 33(1): 75-77
Brunner, L.J.; DiPiro, J.T.; Feldman, S. 1995: Antipyrine pharmacokinetics in the tail-suspended rat model. Journal of Pharmacology and Experimental Therapeutics 274(1): 345-352
Edeki, T.; Turner, P. 1995: Antipyrine repeatability and comparison of the powder and capsule formulations. International Journal of Clinical Pharmacology and Therapeutics 33(2): 70-75
Klebovich, I.; Rautio, A.; Salonpää, P.; Arvela, P.; Pelkonen, O.; Sotaniemi, E.A. 1995: Antipyrine, coumarin and glipizide affect n-acetylation measured by caffeine test. Biomedicine and Pharmacotherapy 49(5): 225-227
Kar, R.K. 1996: Antiquity of some angiosperms in India based on palynological investigation. Rheedea 6(1): 81-91
Chen, B.; Jiang, Q. 1997: Antiquity of the earliest cultivated rice in Central China and its implications. Economic Botany 51(3): 307-310
Gelosa, L. 1998: Antirabies human vaccination in Italy in the period 1987-1995. Igiene Moderna 109(4): 427-442
Foye, W.O.; Chatterji, S. 1996: Antiradiation compounds. 24. Stability of copper (II) complexes of bis(methylthio) and methylthio amino derivatives of 1-methylpyridinium- and 1-methylquinolinium-2-dithioacetic acids in the presence of amino acids, simple peptides, and a protein. Journal of Pharmaceutical Sciences 85(8): 810-814
Varbanets, L.D.; Baraboi, V.A. 1993: Antiradiation effect of Corynebacterium michiganense polysaccharide. Mikrobiolohichnyi Zhurnal 55(5): 56-59
Zham"yansuren, D.; Burgedbazar, B.; Selenge, D.; Zham"yansan, Y.; Lozovskaya, E.L.; Sapezhinskii, I.I. 1993: Antiradical action of the alkaloids from the plant Ammopipthantus mongolicus (Maxim) Cheng at the glycyltryptophan photooxidation. Biofizika 38(6): 1094-1097
Kostyuk, V.A.; Potapovich, A.I. 1998: Antiradical and chelating effects in flavonoid protection against silica-induced cell injury. Archives of Biochemistry and Biophysics 355(1): 43-48
Khramov, O.V.; Venherov, B.B.; Mazur, P.Y.; Danilkov, O.R. 1992: Antirecurrence treatment of chronic bronchitis patients in different regions of Ukraine. Vrachebnoe Delo 1992(9): 82-84
Yoshida, A.; Motoyama, M.; Kosaku, A.; Miyamoto, K. 1997: Antireflective nanoprotuberance array in the transparent wing of a hawkmoth, Cephonodes hylas. Zoological Science (tokyo). 14(5): 737-741,.
Studer, U.E.; Danuser, H.; Thalmann, G.N.; Springer, J.P.; Turner, W.H. 1996: Antireflux nipples or afferent tubular segments in 70 patients with ileal low pressure bladder substitutes: Long-term results of a prospective randomized trial. Journal of Urology 156(6): 1913-1917
Momose, H.; Natsume, O.; Okajima, E.; Yoshii, M.; Hirata, N.; Yamamoto, M.; Suemori, T.; Yamada, K.; Shiomi, T.; Yasukawa, M. 1993: Antireflux operation for vesicoureteral reflux in spina bifida patients. Hinyokika Kiyo. Acta Urologica Japonica 39(8): 705-710
Poirier, N.C.; Taillefer, R.; Topart, P.; Duranceau, A. 1994: Antireflux operations in patients with scleroderma. Annals of Thoracic Surgery 58(1): 66-72; discussion 72-3
Lacy, M.E.; Bevan, J.A.; Boyce, R.W.; Geddes, A.D. 1994: Antiresorptive drugs and trabecular bone turnover: Validation and testing of a computer model. Calcified Tissue International 54(3): 179-185
Arden-Cordone, M.; Siris, E.S.; Lyles, K.W.; Knieriem, A.; Newton, R.A.; Schaffer, V.; Zelenakas, K. 1997: Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone. Calcified Tissue International 60(5): 415-418
Wang, W.Q.; Ip, M.S.; Tsang, K.W.; Lam, K.S. 1998: Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months. Journal of Allergy and Clinical Immunology 101(4 Pt 1): 445-450
Jódar, E.; Muñoz-Torres, M.; Escobar-Jiménez, F.; Quesada, M.; Luna, J.D.; Olea, N. 1997: Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. Journal of Clinical Endocrinology and Metabolism 82(6): 1989-1994
Kostál, M.; Michalková, D.; Hrabcáková, D. 1992: Antireticulin antibodies in sera of children with insulin-dependent diabetes mellitus. Diabetes Research and Clinical Practice 17(3): 183-190
Stevenson, N.R.; Lenard, J. 1993: Antiretroviral activities of hypericin and rose bengal: photodynamic effects on Friend leukemia virus infection of mice. Antiviral Research 21(2): 119-127
Black, P.L.; Downs, M.B.; Lewis, M.G.; Ussery, M.A.; Dreyer, G.B.; Petteway, S.R.; Lambert, D.M. 1993: Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture. Antimicrobial Agents and ChemoTherapy 37(1): 71-77
Clayette, P.; Seman, M.; Martin, M.; Pleskoff, O.; Cherifi, H.; Toutain, B.; Dormont, D. 1994: Antiretroviral activity of an amphotericin B derivative. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1994(15): 95-96
Miolo, G.; Tomanin, R.; De Rossi, A.; Dall'Acqua, F.; Zacchello, F.; Scarpa, M. 1994: Antiretroviral activity of furocoumarins plus UVA light detected by a replication-defective retrovirus. Journal of Photochemistry and Photobiology. B Biology 26(3): 241-247
Mazumder, A.; Wang, S.; Neamati, N.; Nicklaus, M.; Sunder, S.; Chen, J.; Milne, G.W.; Rice, W.G.; Burke, T.R.; Pommier, Y. 1996: Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Journal of Medicinal Chemistry 39(13): 2472-2481
Acosta, E.P.; Fletcher, C.V. 1995: Antiretroviral drug interactions. International Journal of Antimicrobial Agents 5(2): 73-83
Hirsch, M.S.; Conway, B.; D'aquila, R.T.; Johnson, V.A.; Brun Vezinet, F.; Clotet, B.; Demeter, L.M.; Hammer, S.M.; Jacobsen, D.M.; Kuritzkes, D.R.; Loveday, C.; Mellors, J.W.; Vella, S.; Richman, D.D. 1998: Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. JAMA (Journal of the American Medical Association) 279(24): 1984-1991
Wilkinson, D.; Floyd, K.; Gilks, C.F. 1998: Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. Aids 12(13): 1675-1682
Ann, H.-Soo; Ahn, R.-Me; Kim, D.-Seop 1995: Antiretroviral effects of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on the infection of anemia-inducing murine Friend virus. Korean Journal of Pharmacology 31(3): 365-375
Szabó, B.; Tóth, F.D.; Kiss, J.; Kiss, A.; Rák, K. 1993: Antiretroviral immune response and plasma interferon in different phases of chronic granulocytic leukemia. Leukemia Research 17(4): 311-323
Cohen, O.J.; Pantaleo, G.; Holodniy, M.; Fox, C.H.; Orenstein, J.M.; Schnittman, S.; Niu, M.; Graziosi, C.; Pavlakis, G.N.; Lalezari, J.; Bartlett, J.A.; Steigbigel, R.T.; Cohn, J.; Novak, R.; McMahon, D.; Bilello, J.; Fauci, A.S. 1996: Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. Journal of Infectious Diseases 173(4): 849-856
Bollela, V.R.; Machado, A.A. 1996: Antiretroviral therapy. Medicina (ribeirao Preto). 29(4): 449-459
Hug, B.; Kaeser, Y.A.; Haefeli, W.E.; Battegay, M. 1998: Antiretroviral therapy and anticonvulsant drugs. Schweizerische Medizinische Wochenschrift 128(29-30): 1138-1144
Carpenter, C., C.J.; Fischl, M., A.; Hammer, S., M.; Hirsch, M., S.; Jacobsen, D., M.; Katzenstein, D., A.; Montaner, J., S.G.; Richman, D., D.; Saag, M., S.; Schooley, R., T.; Thompson, M., A.; Vella, S.; Yeni, P., G.; Volberding, P., A. 1996: Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. JAMA (Journal of the American Medical Association) 276(2): 146-154
Carpenter, C.C.; Fischl, M.A.; Hammer, S.M.; Hirsch, M.S.; Jacobsen, D.M.; Katzenstein, D.A.; Montaner, J.S.; Richman, D.D.; Saag, M.S.; Schooley, R.T.; Thompson, M.A.; Vella, S.; Yeni, P.G.; Volberding, P.A. 1997: Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA 277(24): 1962-1969
Carpenter, C.C.; Fischl, M.A.; Hammer, S.M.; Hirsch, M.S.; Jacobsen, D.M.; Katzenstein, D.A.; Montaner, J.S.; Richman, D.D.; Saag, M.S.; Schooley, R.T.; Thompson, M.A.; Vella, S.; Yeni, P.G.; Volberding, P.A. 1998: Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA 280(1): 78-86
Krasinski, K. 1994: Antiretroviral therapy for children. Acta Paediatrica . Supplement 400: 63-69
Picard, O. 1994: Antiretroviral therapy for human immunodeficiency virus infection: hope and despair. Biomedicine and Pharmacotherapy 48(2): 85-88
Pizzo, P.A.; Wilfert, C. 1994: Antiretroviral therapy for infection due to human immunodeficiency virus in children. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 19(1): 177-196
Westarp, M.E.; Bartmann, P.; Rössler, J.; Geiger, E.; Westphal, K.P.; Schreiber, H.; Fuchs, D.; Westarp, M.P.; Kornhuber, H.H. 1993: Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis. Neuroreport 4(6): 819-822
Donovan, R.M.; Bush, C.E.; Smereck, S.M.; Moore, E.; Cohen, F.; Saravolatz, L.D. 1994: Antiretroviral therapy is associated with a decrease in unintegrated HIV-1 DNA in pediatric patients. Journal of Acquired Immune Deficiency Syndromes 7(12): 1237-1241
Sadeghi, H.M.; Weiss, L.; Kazatchkine, M.D.; Haeffner-Cavaillon, N. 1995: Antiretroviral therapy suppresses the constitutive production of interleukin-1 associated with human immunodeficiency virus infection. Journal of Infectious Diseases 172(2): 547-550
Rutschmann, O.; Hirschel, B. 1997: Antiretroviral therapy: a guide to the most important trials. Schweizerische Medizinische Wochenschrift 127(11): 436-443
Spooner, K.M.; Lane, H.C.; Masur, H. 1995: Antiretroviral therapy: reference guide to major clinical trials in patients infected with human immunodeficiency virus. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 20(5): 1145-1151
Bray, D.H.; Squire, S.B.; Kawana, A.; Johnson, M.A.; Poulter, L.W. 1993: Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients. Clinical and Experimental Immunology 91(1): 13-17
Matsuoka, H.; Kato, N.; Tsuji, K.; Maruyama, N.; Suzuki, H.; Mihara, M.; Takeda, Y.; Yano, K. 1996: Antirheumatic agents. I. Novel methotrexate derivatives bearing an indoline moiety. Chemical and Pharmaceutical Bulletin 44(7): 1332-1337
Matsuoka, H.; Maruyama, N.; Suzuki, H.; Kuroki, T.; Tsuji, K.; Kato, N.; Ohi, N.; Mihara, M.; Takeda, Y.; Yano, K. 1996: Antirheumatic agents. II. Novel methotrexate derivatives bearing an alkyl-substituted benzene ring. Chemical and Pharmaceutical Bulletin 44(12): 2287-2293
Matsuoka, H.; Kato, N.; Ohi, N.; Miyamoto, K.; Mihara, M.; Takeda, Y. 1997: Antirheumatic agents. III. Novel methotrexate derivatives bearing an indoline ring and a modified ornithine or glutamic acid. Chemical and Pharmaceutical Bulletin 45(7): 1146-1150
Matsuoka, H.; Ohi, N.; Mihara, M.; Suzuki, H.; Miyamoto, K.; Maruyama, N.; Tsuji, K.; Kato, N.; Akimoto, T.; Takeda, Y.; Yano, K.; Kuroki, T. 1997: Antirheumatic agents: novel methotrexate derivatives bearing a benzoxazine or benzothiazine moiety. Journal of Medicinal Chemistry 40(1): 105-111
Theisen-Popp, P.; Müller-Peddinghaus, R. 1994: Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents and Actions 42(1-2): 50-55
Bondeson, J.; Sundler, R. 1993: Antirheumatic gold compounds and penicillamine enhance protein kinase C-mediated activation of the arachidonate-mobilizing phospholipase A2 in mouse macrophages. Journal of Leukocyte Biology 54(4): 329-335
Tebbe, M.J.; Spitzer, W.A.; Victor, F.; Miller, S.C.; Lee, C.C.; Sattelberg, T.R.; McKinney, E.; Tang, J.C. 1997: Antirhino/enteroviral vinylacetylene benzimidazoles: a study of their activity and oral plasma levels in mice. Journal of Medicinal Chemistry 40(24): 3937-3946
Bailey, T.R.; Diana, G.D.; Kowalczyk, P.J.; Akullian, V.; Eissenstat, M.A.; Cutcliffe, D.; Mallamo, J.P.; Carabateas, P.M.; Pevear, D.C. 1992: Antirhinoviral activity of heterocyclic analogs of Win 54954. Journal of Medicinal Chemistry 35(24): 4628-4633
Press, J.; Palayew, K.; Laxer, R.M.; Elkon, K.; Eddy, A.; Rakoff, D.; Silverman, E.D. 1996: Antiribosomal P antibodies in pediatric patients with systemic lupus erythematosus and psychosis. Arthritis and Rheumatism 39(4): 671-676
Teh, L.S.; Lee, M.K.; Wang, F.; Manivasagar, M.; Charles, P.J.; Nicholson, G.D.; Hay, E.M.; Isenberg, D.A.; Amos, N.; Williams, B.D. 1993: Antiribosomal P protein antibodies in different populations of patients with systemic lupus erythematosus. British Journal of Rheumatology 32(8): 663-665
Superti, F.; Ammendolia, M.G.; Valenti, P.; Seganti, L. 1997: Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Medical Microbiology and Immunology 186(2-3): 83-91
Ruggeri, F.M.; Johansen, K.; Basile, G.; Kraehenbuhl, J.P.; Svensson, L. 1998: Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. Journal of Virology 72(4): 2708-2714
Guemes, J.; Mateu, I.; Sanchez-Gomez, P. 1993: Antirrhinum subbaeticum Guemes, Mateu and Sanchez-Gomez (Scrophulariaceae), a new species from the Iberian Peninsula. Anales del Jardin Botanico de Madrid 51(2): 237-247
Katsanis, J.; Kortenkamp, S.; Iacono, W.G.; Grove, W.M. 1997: Antisaccade performance in patients with schizophrenia and affective disorder. Journal of Abnormal Psychology 106(3): 468-472
O'Driscoll, G.A.; Lenzenweger, M.F.; Holzman, P.S. 1998: Antisaccades and smooth pursuit eye tracking and schizotypy. Archives of General Psychiatry 55(9): 837-843
Allen, J.S.; Lambert, A.J.; Johnson, F.Y.; Schmidt, K.; Nero, K.L. 1996: Antisaccadic eye movements and attentional asymmetry in schizophrenia in three Pacific populations. Acta Psychiatrica Scandinavica 94(4): 258-265
Kasai, T.; Ishikawa, Y.; Inoue, K.; Tsujimura, M.; Hasegawa, T. 1995: Antiscorbutic activity of 6-bromo-6-deoxy-L-ascorbic acid in the guinea pig. International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 65(1): 36-39
Yuki, H.; Kamato, T.; Nishida, A.; Fujihara, A.; Takeda, M.; Miyata, K. 1993: Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs. Japanese Journal of Pharmacology 63(3): 345-351
Beubler, E.; Badhri, P.; Schirgi-Degen, A. 1993: Antisecretory activities of orally administered loperamide and loperamide oxide on intestinal secretion in rats. Journal of Pharmacy and Pharmacology 45(9): 803-806